# CIBC Pillar 3 Report and Supplementary Regulatory Capital Disclosure

For the period ended January 31, 2025

For further information, please contact:
Geoff Weiss, Senior Vice-President, Investor Relations and Performance Measurement (416) 980-5093
Jason Patchett, Senior Director, Investor Relations (416) 980-8691

## TABLE OF CONTENTS

This document is unaudited and should be read in conjunction with our quarterly report to shareholders and news release for Q1/25, and our 2024 Annual Report (including audited consolidated financial statements and accompanying management's discussion and analysis), which is available on SEDAR+ at www.sedarplus.com. Additional financial information is also available through our quarterly investor presentations as well as the quarterly conference call webcast. CIBC prepares its consolidated financial statements in accordance with International Financial Reporting Standards (IFRS or GAAP). For Basel-related terms used in this package, refer to the Glossary.

The composition of the measures in this document and the disclosures, including the format of the templates herein, are calculated and disclosed pursuant to guidelines issued by the Office of the Superintendent of Financial Institutions (OSFI), including the Capital Adequacy Requirements (CAR) Guideline, Total Loss Absorbing Capacity (TLAC) Guideline, the Leverage Requirements Guideline and the Pillar 3 Disclosure Requirements Guideline.

All amounts in this document are in millions of Canadian dollars, unless otherwise stated.

## PILLAR 3 REPORT

| Pillar 3 report index | 1 |
|---|---|
| KM1: Key metrics (at consolidated group level) | 3 |
| KM2: Key metrics - TLAC requirements (at resolution group level) | 4 |
| OV1: Overview of risk-weighted assets (RWA) | 5 |
| CMS1: Comparison of modelled and standardized RWA at risk level | 6 |
| CMS2: Comparison of modelled and standardized RWA for credit risk at asset class level | 8 |
| Changes in RWA | 11 |
| LI1: Differences between accounting and regulatory scopes of consolidation and mapping of financial statement categories with regulatory risk categories | 12 |
| LI2: Main sources of differences between regulatory exposure amounts and carrying values in financial statements | 13 |
| PV1: Prudent valuation adjustments (PVAs) | 14 |
| CC1: Composition of regulatory capital | 16 |
| CC2: Reconciliation of regulatory capital to balance sheet | 18 |
| Changes in regulatory capital | 20 |
| TLAC1: TLAC composition (at resolution group level) | 21 |
| TLAC3: Resolution entity - Creditor ranking at legal entity level | 22 |
| CCyB1: Geographical distribution of credit exposures used in the calculation of the bank-specific countercyclical capital buffer requirement | 24 |
| LR1: Summary comparison of accounting assets vs. leverage ratio exposure measure | 26 |
| LR2: Leverage ratio common disclosure template | 26 |
| CR1: Credit quality of assets | 27 |
| CR2: Changes in stock of defaulted loans and debt securities | 29 |
| CR3: Credit risk mitigation (CRM) techniques – overview | 30 |
| CR4: Standardized approach (SA) – Credit risk exposure and CRM effects | 31 |
| CR5: SA - exposures by asset classes and risk-weights | 34 |
| CR6: Internal ratings based (IRB) - Credit risk exposures by portfolio and probability of default (PD) range | 39 |
| CR10: IRB (specialized lending and equities under the simple risk-weight method) | 54 |
| CCR1: Analysis of counterparty credit risk exposure by approach | 56 |
| CCR3: SA - counterparty credit risk exposures by regulatory portfolio and risk-weights | 58 |
| CCR4: IRB - counterparty credit risk exposures by portfolio and PD scale | 60 |
| CCR5: Composition of collateral for counterparty credit risk exposure | 70 |
| CCR6: Credit derivatives exposures | 72 |
| CCR8: Exposures to central counterparties | 73 |
| SEC1: Securitization exposures in the banking book | 74 |
| SEC2: Securitization exposures in the trading book | 76 |
| SEC3: Securitization exposures in the banking book and associated regulatory capital requirements - bank acting as originator or as sponsor | 78 |
| SEC4: Securitization exposures in the banking book and associated regulatory capital requirements - bank acting as investor | 81 |

## SUPPLEMENTARY REGULATORY CAPITAL DISCLOSURES

| Disclosures provided to address Enhanced Disclosure Task Force recommendations | 86 |
|---|---|
| Credit exposure - Exposure at default (EAD) | 87 |
| Credit exposure - Geographic concentration | 88 |
| Credit exposure - Maturity profile | 89 |
| Credit risk associated with derivatives | 90 |
| Advanced internal ratings-based (AIRB) credit risk exposure - Loss experience | 91 |
| AIRB credit risk exposure - Back-testing | 92 |
| Glossary | 93 |

***

## PILLAR 3 REPORT INDEX

The index below provides a listing of Pillar 3 disclosure requirements issued by the Basel Committee of Banking Supervision (BCBS), which are currently effective for CIBC, along with their locations. As indicated, the disclosures that are located in our 2024 Annual Report, Q1/25 supplementary packages, and our 2024 Management Proxy Circular, can be found on our website (www.cibc.com). No information on CIBC's website, including the supplementary packages, should be considered incorporated herein by reference.

The credit risk framework within the CAR Guideline issued by OSFI is inclusive of requirements relating to counterparty credit risk, and securitization activities, as well as other items such as settlement risk, equity investments in funds, and amounts below the threshold for capital deductions which are subject to a 250% risk-weight. Pages 86 to 91 of this document and disclosures in our 2024 Annual Report are prepared on a basis where these amounts are considered to be regulatory exposures or RWA relating to credit risk (i.e., credit risk related disclosures are generally inclusive of all or some of these amounts, depending upon the nature of the applicable disclosure), whereas the Pillar 3 report on pages 1 to 85 of this document provides a disaggregation of these amounts.

| Topic | Identifier | Table and templates | Frequency | Pillar 3 Report Page references | Q1/25 Quarterly Report Page references | 2024 Annual Report Page references | Supplementary Financial Information |
|---|---|---|---|---|---|---|---|
| Overview of risk management, key prudential metrics and RWA | KM1 | Key metrics - (at consolidated group level) | Quarterly | 3 | 19 | 39-40 | |
| | KM2 | Key metrics - TLAC requirements (at resolution group level) | Quarterly | 4 | 19 | 39-40 | |
| | OVA | Bank risk management approach | Annual | 5 | | 35, 45-52, 56-58, 60, 65, 68, 71, 73, 80-84 | |
| | OV1 | Overview of RWA | Quarterly | 5 | | | |
| Comparison of modelled and standardized RWA | CMS1 | Comparison of modelled and standardized RWA at risk level | Quarterly | 6 | | 38 | |
| | CMS2 | Comparison of modelled and standardized RWA for credit risk at asset class level | Quarterly | 8 | | 38 | |
| Linkages between financial statements and regulatory exposures | LI1 | Differences between accounting and regulatory scopes of consolidation and mapping of financial statement categories with regulatory risk categories | Quarterly | 12 | | | |
| | LI2 | Main sources of differences between regulatory exposure amounts and carrying values in financial statements | Quarterly | 13 | | | |
| | LIA | Explanations of differences between accounting and regulatory exposure amounts | Quarterly | 12-13 | | 129 | |
| | PV1 | Prudent valuation adjustments (PVAs) | Quarterly | 14 | | | |
| Asset encumbrance | ENC | Asset encumbrance | Quarterly | | | 34 | 74 |
| Remuneration | REMA | Remuneration policy | Annual | | | | 2024 Management Proxy Circular |
| | REM1 | Remuneration awarded during the financial year | Annual | | | | |
| | REM2 | Special payments | Annual | | | | |
| | REM3 | Deferred remuneration | Annual | | | | |
| Composition of capital and TLAC | CC1 | Composition of regulatory capital | Quarterly | 16 | | | |
| | CC2 | Reconciliation of regulatory capital to balance sheet | Quarterly | 18 | | | |
| | CCA | Main features of regulatory capital instruments and of other TLAC-eligible instruments (1) | Quarterly | 18-19, 65 | | 37, 39-40, 164 | |
| | TLAC1 | TLAC composition (at resolution group level) | Quarterly | 21 | | | |
| | TLAC2 | Material subgroup entity - creditor ranking at legal entity level | Quarterly | n/a (2) | | | |
| | TLAC3 | Resolution entity - creditor ranking at legal entity level | Quarterly | 22 | | | |
| Macroprudential supervisory measures | GSIB1 | Disclosure of global systemically important bank (G-SIB) indicators | Annual | | 22 | | |
| | CCyB1 | Geographical distribution of credit exposures used in the calculation of the bank-specific countercyclical capital buffer requirement | Quarterly | 24 | | | |
| Leverage ratio | LR1 | Summary comparison of accounting assets vs. leverage ratio exposure measure | Quarterly | 26 | | | |
| | LR2 | Leverage ratio common disclosure template | Quarterly | 26 | | | |
| Credit risk | CRA | General information about credit risk | Annual | | | 57, 58, 59 | |
| | CR1 | Credit quality of assets | Quarterly | 27 | | | 23-34 |
| | CR2 | Changes in stock of defaulted loans and debt securities | Quarterly | 29 | | 58, 66, 79, 86-87, 120, 144 | |
| | CRB | Additional disclosure related to the credit quality of assets | Annual | 27 | | | |
| | CRC | Qualitative disclosure requirements related to CRM techniques | Annual | | | 58, 67, 154 | |
| | CR3 | CRM techniques - overview | Quarterly | 30 | | | |
| | CRD | Qualitative disclosures on banks' use of external credit ratings under the SA for credit risk | Annual | | | 62 | |
| | CR4 | SA - credit risk exposure and CRM effects | Quarterly | 31 | | | |
| | CR5 | SA - exposures by asset classes and risk weights | Quarterly | 34 | | | |
| Credit risk (continued) | CR6 | IRB - Credit risk exposures by portfolio and PD range (3) | Quarterly | 39 | | 38, 52, 57-61 | |
| | CR7 | IRB - Effect on RWA of credit derivatives used as CRM techniques | Quarterly | n/a (4) | | | |
| | CR8 | RWA flow statements of credit risk exposures under IRB | Quarterly | 11 | | | |
| | CR9 | IRB - Back-testing of PD per portfolio (3) | Annual | n/a (5) | | | |
| | CR10 | IRB (specialized lending and equities under the simple risk-weight method) | Quarterly | 54 | | | |
| Counterparty credit risk | CCRA | Qualitative disclosure related to counterparty credit risk | Annual | | | 58, 62, 79, 152, 154 | |
| | CCR1 | Analysis of counterparty credit risk exposure by approach | Quarterly | 56 | | | |
| | CCR3 | SA - counterparty credit risk exposures by regulatory portfolio and risk-weights | Quarterly | 58 | | | |
| | CCR4 | IRB - counterparty credit risk exposures by portfolio and PD scale (3) | Quarterly | 60 | | | |
| | CCR5 | Composition of collateral for counterparty credit risk exposure | Quarterly | 70 | | | |
| | CCR6 | Credit derivatives exposures | Quarterly | 72 | | | |
| | CCR7 | RWA flow statements of counterparty credit risk exposures under the Internal Model Method (IMM) | Quarterly | 11 | | | |
| | CCR8 | Exposures to central counterparties | Quarterly | 73 | | | |
| Securitization (6) | SECA | Qualitative disclosure requirements related to securitization exposures | Annual | | | 43-44, 67, 117, 121, 144 | |
| | SEC1 | Securitization exposures in the banking book | Quarterly | 74 | | | |
| | SEC2 | Securitization exposures in the trading book | Quarterly | 76 | | | |
| | SEC3 | Securitization exposures in the banking book and associated regulatory capital requirements - bank acting as originator or as sponsor | Quarterly | 78 | | | |
| | SEC4 | Securitization exposures in the banking book and associated regulatory capital requirements - bank acting as investor | Quarterly | 81 | | | |
| Market risk | MRA | Qualitative disclosure requirements related to market risk | Annual | | | 68-69 | |
| | MRB | Qualitative disclosures for banks using the Internal Models Approach (IMA) | Annual | | | n/a (7) | |
| | MR1 | Market risk under the SA | Quarterly | 84 | | | |
| | MR2 | RWA flow statements of market risk exposures under an IMA | Quarterly | n/a (7) | | | |
| | MR3 | IMA values for trading purposes | Quarterly | n/a (7) | | | |
| | MR4 | Comparison of Value-at-Risk (VaR) estimates with gains/losses | Quarterly | n/a (7) | | | |
| Credit valuation adjustment risk | CVAA | General qualitative disclosure requirements related to CVA | Annual | | | 38-39, 47, 62, 130 | |
| | CVA1 | The reduced basic approach for CVA (BA-CVA) | Quarterly | | 85 | | |
| | CVA2 | The full basic approach for CVA (BA-CVA) | Quarterly | n/a (7) | | | |
| | CVAB | Qualitative disclosures for banks using the SA-CVA | Annual | | 85 | | 38-39, 62 |
| | CVA3 | The standardized approach for CVA (SA-CVA) | Quarterly | 85 | | | |
| | CVA4 | RWA flow statements of CVA risk exposures under SA-CVA | Quarterly | 85 | | | |
| Liquidity risk | LIQA | Liquidity risk management | Annual | | | 73-80 | |
| | LIQ1 | Liquidity Coverage Ratio (LCR) | Quarterly | 34-35 | | 75 | |
| | LIQ2 | Net Stable Funding Ratio (NSFR) | Quarterly | 35-36 | | 77 | |
| Operational risk | ORA | General qualitative information on a bank's operational risk framework | Annual | | | 80-82 | |
| | OR1 | Historical losses | Annual | n/a (5) | | | |
| | OR2 | Business indicator and subcomponents | Annual | n/a (5) | | | |
| | OR3 | Minimum required operational risk capital | Annual | n/a (5) | | | |
| Interest Rate Risk in the Banking Book | IRRBB | Qualitative and quantitative disclosure on interest rate risk in the banking book (IRRBB) | Annual | | | 71-72 | |

***

## PILLAR 3 REPORT (continued)

### PILLAR 3 REPORT INDEX (continued)

| Topic | Identifier | Table and templates | Frequency | Pillar 3 Report Page references | Q1/25 Quarterly Report Page references | 2024 Annual Report Page references | Supplementary Financial Information |
|---|---|---|---|---|---|---|---|
| Credit risk (continued) | CR6 | IRB - Credit risk exposures by portfolio and PD range (3) | Quarterly | 39 | | 38, 52, 57-61 | |
| | CR7 | IRB - Effect on RWA of credit derivatives used as CRM techniques | Quarterly | n/a (4) | | | |
| | CR8 | RWA flow statements of credit risk exposures under IRB | Quarterly | 11 | | | |
| | CR9 | IRB - Back-testing of PD per portfolio (3) | Annual | n/a (5) | | | |
| | CR10 | IRB (specialized lending and equities under the simple risk-weight method) | Quarterly | 54 | | | |
| Counterparty credit risk | CCRA | Qualitative disclosure related to counterparty credit risk | Annual | | | 58, 62, 79, 152, 154 | |
| | CCR1 | Analysis of counterparty credit risk exposure by approach | Quarterly | 56 | | | |
| | CCR3 | SA - counterparty credit risk exposures by regulatory portfolio and risk-weights | Quarterly | 58 | | | |
| | CCR4 | IRB - counterparty credit risk exposures by portfolio and PD scale (3) | Quarterly | 60 | | | |
| | CCR5 | Composition of collateral for counterparty credit risk exposure | Quarterly | 70 | | | |
| | CCR6 | Credit derivatives exposures | Quarterly | 72 | | | |
| | CCR7 | RWA flow statements of counterparty credit risk exposures under the Internal Model Method (IMM) | Quarterly | 11 | | | |
| | CCR8 | Exposures to central counterparties | Quarterly | 73 | | | |
| Securitization (6) | SECA | Qualitative disclosure requirements related to securitization exposures | Annual | | | 43-44, 67, 117, 121, 144 | |
| | SEC1 | Securitization exposures in the banking book | Quarterly | 74 | | | |
| | SEC2 | Securitization exposures in the trading book | Quarterly | 76 | | | |
| | SEC3 | Securitization exposures in the banking book and associated regulatory capital requirements - bank acting as originator or as sponsor | Quarterly | 78 | | | |
| | SEC4 | Securitization exposures in the banking book and associated regulatory capital requirements - bank acting as investor | Quarterly | 81 | | | |
| Market risk | MRA | Qualitative disclosure requirements related to market risk | Annual | | | 68-69 | |
| | MRB | Qualitative disclosures for banks using the Internal Models Approach (IMA) | Annual | | | n/a (7) | |
| | MR1 | Market risk under the SA | Quarterly | 84 | | | |
| | MR2 | RWA flow statements of market risk exposures under an IMA | Quarterly | n/a (7) | | | |
| | MR3 | IMA values for trading purposes | Quarterly | n/a (7) | | | |
| | MR4 | Comparison of Value-at-Risk (VaR) estimates with gains/losses | Quarterly | n/a (7) | | | |
| Credit valuation adjustment risk | CVAA | General qualitative disclosure requirements related to CVA | Annual | | | 38-39, 47, 62, 130 | |
| | CVA1 | The reduced basic approach for CVA (BA-CVA) | Quarterly | | 85 | | |
| | CVA2 | The full basic approach for CVA (BA-CVA) | Quarterly | n/a (7) | | | |
| | CVAB | Qualitative disclosures for banks using the SA-CVA | Annual | | 85 | | 38-39, 62 |
| | CVA3 | The standardized approach for CVA (SA-CVA) | Quarterly | 85 | | | |
| | CVA4 | RWA flow statements of CVA risk exposures under SA-CVA | Quarterly | 85 | | | |
| Liquidity risk | LIQA | Liquidity risk management | Annual | | | 73-80 | |
| | LIQ1 | Liquidity Coverage Ratio (LCR) | Quarterly | 34-35 | | 75 | |
| | LIQ2 | Net Stable Funding Ratio (NSFR) | Quarterly | 35-36 | | 77 | |
| Operational risk | ORA | General qualitative information on a bank's operational risk framework | Annual | | | 80-82 | |
| | OR1 | Historical losses | Annual | n/a (5) | | | |
| | OR2 | Business indicator and subcomponents | Annual | n/a (5) | | | |
| | OR3 | Minimum required operational risk capital | Annual | n/a (5) | | | |
| Interest Rate Risk in the Banking Book | IRRBB | Qualitative and quantitative disclosure on interest rate risk in the banking book (IRRBB) | Annual | | | 71-72 | |

(1) CCA is available at https://www.cibc.com/en/about-cibc/investor-relations/regulatory-capital-instruments.html.
(2) CIBC is not a G-SIB.
(3) There are several key differences between Basel and IFRS 9 which could lead to significantly different estimates for PD and loss given default (LGD). Basel parameters reflect long run historical experience including periods of downturn and adjustments for conservatism, whereas IFRS 9 parameters are point-in-time estimates based on forward-looking information. See the "Accounting and control matters" section in our 2024 Annual Report for additional details.
(4) As at January 31, 2025, the use of credit derivatives reduced RWA relating to corporate exposures under the AIRB approach by nil.
(5) Templates CR9, OR1, OR2, OR3, are only required to be disclosed on an annual basis. Refer to CIBC's Pillar 3 Report and Supplementary Regulatory Capital Disclosure for the period ended October 31, 2024, which may be found on our website at https://www.cibc.com/en/about-cibc/investor-relations/quarterly-results.html.
(6) Excludes mortgages securitized through programs sponsored by the Canada Mortgage Housing Corporation, including the creation of mortgage-backed securities (MBS) under the National Housing Act MBS Program and the Canada Mortgage Bond Program. These exposures are risk-weighted under the credit risk framework.
(7) CIBC does not apply Internal Model Approach for market risk nor Full Basic Approach for CVA.
n/a Not applicable.

## KM1: KEY METRICS (AT CONSOLIDATED GROUP LEVEL)

($ millions)

| | | Q1/25 a | Q4/24 b | Q3/24 c | Q2/24 d | Q1/24 e |
|---|---|---|---|---|---|---|
| **Available capital (amounts)** | | | | | | |
| 1 | Common Equity Tier 1 (CET1) | 46,213 | 44,516 | 43,784 | 42,728 | 41,160 |
| 2 | Tier 1 | 51,574 | 49,481 | 48,751 | 47,845 | 46,103 |
| 3 | Total capital | 59,114 | 56,809 | 56,145 | 55,478 | 53,779 |
| **Risk-weighted assets (amounts)** | | | | | | |
| 4 | Total RWA | 341,930 | 333,502 | 329,202 | 326,514 | 316,333 |
| 4a | Total RWA (pre-floor) | 341,930 | 333,502 | 329,202 | 326,514 | 316,333 |
| **Risk-based capital ratios as a percentage of RWA** | | | | | | |
| 5 | CET1 ratio | 13.5% | 13.3% | 13.3% | 13.1% | 13.0% |
| 5b | CET1 ratio (pre-floor ratio) | 13.5% | 13.3% | 13.3% | 13.1% | 13.0% |
| 6 | Tier 1 ratio | 15.1% | 14.8% | 14.8% | 14.7% | 14.6% |
| 6b | Tier 1 ratio (pre-floor ratio) | 15.1% | 14.8% | 14.8% | 14.7% | 14.6% |
| 7 | Total capital ratio | 17.3% | 17.0% | 17.1% | 17.0% | 17.0% |
| 7b | Total capital ratio (pre-floor ratio) | 17.3% | 17.0% | 17.1% | 17.0% | 17.0% |
| **Additional CET1 buffer requirement as a percentage of RWA** | | | | | | |
| 8 | Capital conservation buffer requirement (2.5% from 2019) | 2.5% | 2.5% | 2.5% | 2.5% | 2.5% |
| 9 | Countercyclical buffer requirement (1) | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| 10 | Bank G-SIB and/or D-SIB additional requirements | 1.0% | 1.0% | 1.0% | 1.0% | 1.0% |
| 11 | Total of bank CET1 specific buffer requirements (row 8 + 9 + 10) | 3.5% | 3.5% | 3.5% | 3.5% | 3.5% |
| 12 | CET1 available after meeting the bank's minimum capital requirements (2) | 9.0% | 8.8% | 8.8% | 8.6% | 8.5% |
| **Leverage Ratio** | | | | | | |
| 13 | Total leverage ratio exposure measure | 1,205,520 | 1,155,432 | 1,133,983 | 1,112,411 | 1,080,906 |
| 14 | Leverage ratio (row 2 / row 13) | 4.3% | 4.3% | 4.3% | 4.3% | 4.3% |

(1) Bank specific countercyclical buffer requirement of 0.03% in Q1/25 (Q4/24: 0.03%) is the amount which is determined based on our weighted average private sector exposures in jurisdictions identified by the BCBS.
(2) Calculated by row 5 above minus the CET 1 regulatory minimum requirement of 4.5%.

## KM2: KEY METRICS - TLAC REQUIREMENTS (AT RESOLUTION GROUP LEVEL) (1)

($ millions)

| | | Q1/25 a | Q4/24 b | Q3/24 c | Q2/24 d | Q1/24 e |
|---|---|---|---|---|---|---|
| 1 | TLAC available | 107,533 | 101,062 | 99,150 | 95,890 | 99,812 |
| 2 | Total RWA at the level of the resolution group | 341,930 | 333,502 | 329,202 | 326,514 | 316,333 |
| 3 | TLAC ratio: TLAC as a percentage of RWA (row 1 / row 2) (%) | 31.4% | 30.3% | 30.1% | 29.4% | 31.6% |
| 4 | Leverage ratio exposure measure at the level of the resolution group | 1,205,520 | 1,155,432 | 1,133,983 | 1,112,411 | 1,080,906 |
| 5 | TLAC Leverage Ratio: TLAC as a percentage of leverage ratio exposure measure (row 1 / row 4) (%) | 8.9% | 8.7% | 8.7% | 8.6% | 9.2% |
| 6a | Does the subordination exemption in the antepenultimate paragraph of Section 11 of the Financial Stability Board (FSB) TLAC Term Sheet apply? | Yes | Yes | Yes | Yes | Yes |
| 6b | Does the subordination exemption in the penultimate paragraph of Section 11 of the FSB TLAC Term Sheet apply? | No | No | No | No | No |
| 6c | If the capped subordination exemption applies, the amount of funding issued that ranks pari passu with Excluded Liabilities and that is recognized as external TLAC, divided by funding issued that ranks pari passu with Excluded Liabilities and that would be recognized as external TLAC if no cap was applied (%) | n/a | n/a | n/a | n/a | n/a |

(1) As a domestic systemically important bank (D-SIB), CIBC is subject to a target risk-based TLAC Ratio (which comprises a minimum risk-based TLAC ratio of 21.5% plus the then-applicable Domestic Stability Buffer (DSB)) and a minimum TLAC Leverage Ratio of 7.25%.
n/a Not applicable.

## OV1: OVERVIEW OF RWA (1)

($ millions)

| | | Q1/25 a | Q4/24 b | Q3/24 c | Q2/24 d | Q1/24 e | Q1/24 f |
|---|---|---|---|---|---|---|---|
| | **RWA requirements** | | | | | | **Minimum capital RWA** |
| 1 | Credit risk (excluding counterparty credit risk) | 240,995 | 234,005 |
| 2 | Of which: SA (2) | 19,917 | 24,047 | 23,822 | 22,725 | 22,785 | 21,502 |
| 3 | Of which: foundation internal ratings-based (FIRB) approach | 1,924 | 24,047 | 23,822 | 22,725 | 22,785 | 21,502 |
| 4 | Of which: supervisory slotting approach | 3,100 | 38,748 | 38,212 | 40,699 | 40,617 | 38,831 |
| 5 | Of which: AIRB approach | 6 | 78 | 90 | 109 | 73 | 162 |
| 6 | Counterparty credit risk (3) | 14,887 | 186,084 | 180,982 | 181,390 | 177,520 | 173,510 |
| 7 | Of which: SA for counterparty credit risk (SA-CCR) | 923 | 11,539 | 10,167 | 8,917 | 9,214 | 8,333 |
| 8 | Of which: IMM | 30 | 378 | 338 | 242 | 356 | 291 |
| 9 | Of which: other CCR | 442 | 5,519 | 5,143 | 4,526 | 4,560 | 4,046 |
| 10 | CVA | 451 | 5,642 | 4,686 | 4,149 | 4,298 | 3,996 |
| 11 | Equity investments in funds - look-through approach (4) | 287 | 3,588 | 3,381 | 3,082 | 3,301 | 3,579 |
| 12 | Equity investments in funds - mandate-based approach (4) | 187 | 2,341 | 2,160 | 2,131 | 2,072 | 1,904 |
| 13 | Settlement risk | 2 | 29 | 36 | 46 | 37 | 45 |
| 14 | Securitization exposures in banking book | 765 | 9,559 | 9,235 | 7,514 | 7,443 | 7,154 |
| 15 | Of which: internal ratings-based approach (IRBA) | 232 | 2,905 | 2,370 | 1,236 | 1,953 | 1,942 |
| 16 | Of which: external ratings-based approach (ERBA), including internal assessment approach (IAA) | 266 | 3,317 | 3,193 | 3,071 | 2,612 | 2,521 |
| 17 | Of which: SA (5) | 267 | 3,337 | 3,672 | 3,207 | 2,878 | 2,691 |
| 18 | Market risk | 964 | 12,049 | 12,188 | 11,112 | 12,787 | 11,634 |
| 19 | Of which: SA | 964 | 12,049 | 12,188 | 11,112 | 12,787 | 11,634 |
| 20 | Of which: IMM | - | - | - | - | - | - |
| 21 | Capital charge for switch between trading book and banking book | - | - | - | - | - | - |
| 22 | Operational risk | 3,823 | 47,793 | 46,811 | 45,763 | 45,046 | 44,347 |
| 23 | Amounts below the thresholds for deduction (subject to 250% risk-weight) | 486 | 6,075 | 6,418 | 5,714 | 5,619 | 5,332 |
| 24 | Output floor applied | - | - | - | - | - | - |
| 25 | Floor adjustment (before application of transitional cap) | - | - | - | - | - | - |
| 26 | Floor adjustment (after application of transitional cap) | - | - | - | - | - | - |
| 27 | Total (1+6+10+11+12+13+14+18+21+22+23+24) | 27,354 | 341,930 | 333,502 | 329,202 | 326,514 | 316,333 |

(1) For changes in RWA, refer to table "Changes in RWA".
(2) Includes RWA of \$1,541 million (Q4/24: \$1,427 million) relating to non-trading equity investments.
(3) Comprises derivative and repo-style transactions.
(4) Equity investments in funds are only included in table OV1.
(5) Includes securitization exposures that are risk-weighted at 1250%.

## CMS1 - COMPARISON OF MODELLED AND STANDARDIZED RWA AT RISK LEVEL

($ millions)

| | | Q1/25 a | Q1/25 b | Q1/25 c | Q1/25 d |
|---|---|---|---|---|---|
| | | RWA for modelled approaches that banks have supervisory approval to use | RWA for portfolios where standardized approaches are used | Total actual RWA | RWA calculated using full standardized approach |
| 1 | Credit risk (excluding counterparty credit risk) | 224,910 | 24,047 | 248,957 | 397,881 |
| 2 | Counterparty credit risk | 10,690 | 849 | 11,539 | 29,322 |
| 3 | CVA | - | 3,588 | 3,588 | 3,588 |
| 4 | Securitization exposures in the banking book | 5,339 | 4,220 | 9,559 | 21,608 |
| 5 | Market risk | 12,049 | - | 12,049 | 12,049 |
| 6 | Operational risk | 47,793 | - | 47,793 | 47,793 |
| 7 | Residual RWA | 8,445 | - | 8,445 | 8,445 |
| 8 | Total | 240,939 | 100,991 | 341,930 | 520,686 |

($ millions)

| | | Q4/24 a | Q4/24 b | Q4/24 c | Q4/24 d |
|---|---|---|---|---|---|
| | | RWA for modelled approaches that banks have supervisory approval to use | RWA for portfolios where standardized approaches are used | Total actual RWA | RWA calculated using full standardized approach |
| 1 | Credit risk (excluding counterparty credit risk) | 219,284 | 23,822 | 243,106 | 391,023 |
| 2 | Counterparty credit risk | 9,357 | 810 | 10,167 | 24,326 |
| 3 | CVA | - | 3,381 | 3,381 | 3,381 |
| 4 | Securitization exposures in the banking book | 4,580 | 4,655 | 9,235 | 18,902 |
| 5 | Market risk | 12,188 | - | 12,188 | 12,188 |
| 6 | Operational risk | 46,811 | - | 46,811 | 46,811 |
| 7 | Residual RWA | 8,614 | - | 8,614 | 8,614 |
| 8 | Total | 233,221 | 100,281 | 333,502 | 505,245 |

($ millions)

| | | Q3/24 a | Q3/24 b | Q3/24 c | Q3/24 d |
|---|---|---|---|---|---|
| | | RWA for modelled approaches that banks have supervisory approval to use | RWA for portfolios where standardized approaches are used | Total actual RWA | RWA calculated using full standardized approach |
| 1 | Credit risk (excluding counterparty credit risk) | 222,198 | 22,725 | 244,923 | 393,063 |
| 2 | Counterparty credit risk | 8,173 | 744 | 8,917 | 22,446 |
| 3 | CVA | - | 3,082 | 3,082 | 3,082 |
| 4 | Securitization exposures in the banking book | 3,242 | 4,272 | 7,514 | 6,729 |
| 5 | Market risk | 11,112 | - | 11,112 | 11,112 |
| 6 | Operational risk | 45,763 | - | 45,763 | 45,763 |
| 7 | Residual RWA | 7,891 | - | 7,891 | 7,891 |
| 8 | Total | 233,613 | 95,589 | 329,202 | 490,086 |

## CMS1 – COMPARISON OF MODELLED AND STANDARDIZED RWA AT RISK LEVEL (continued)

($ millions)

| | | Q2/24 a | Q2/24 b | Q2/24 c | Q2/24 d |
|---|---|---|---|---|---|
| | | RWA for modelled approaches that banks have supervisory approval to use | RWA for portfolios where standardized approaches are used | Total actual RWA | RWA calculated using full standardized approach |
| 1 | Credit risk (excluding counterparty credit risk) | 218,210 | 22,785 | 240,995 | 393,042 |
| 2 | Counterparty credit risk | 8,459 | 755 | 9,214 | 24,094 |
| 3 | CVA | - | 3,301 | 3,301 | 3,301 |
| 4 | Securitization exposures in the banking book | 3,864 | 3,579 | 7,443 | 6,070 |
| 5 | Market risk | 12,787 | - | 12,787 | 12,787 |
| 6 | Operational risk | 45,046 | - | 45,046 | 45,046 |
| 7 | Residual RWA | 7,728 | - | 7,728 | 7,728 |
| 8 | Total | 230,533 | 95,981 | 326,514 | 492,068 |

($ millions)

| | | Q1/24 a | Q1/24 b | Q1/24 c | Q1/24 d |
|---|---|---|---|---|---|
| | | RWA for modelled approaches that banks have supervisory approval to use | RWA for portfolios where standardized approaches are used | Total actual RWA | RWA calculated using full standardized approach |
| 1 | Credit risk (excluding counterparty credit risk) | 212,503 | 21,502 | 234,005 | 385,847 |
| 2 | Counterparty credit risk | 7,623 | 710 | 8,333 | 22,227 |
| 3 | CVA | - | 3,579 | 3,579 | 3,579 |
| 4 | Securitization exposures in the banking book | 3,799 | 3,355 | 7,154 | 5,916 |
| 5 | Market risk | 11,634 | - | 11,634 | 11,634 |
| 6 | Operational risk | 44,347 | - | 44,347 | 44,347 |
| 7 | Residual RWA | 7,281 | - | 7,281 | 7,281 |
| 8 | Total | 223,925 | 92,408 | 316,333 | 480,831 |

## CMS2 – COMPARISON OF MODELLED AND STANDARDIZED RWA FOR CREDIT RISK AT ASSET CLASS LEVEL

($ millions)

| | | Q1/25 a | Q1/25 b | Q1/25 c | Q1/25 d |
|---|---|---|---|---|---|
| | | RWA for modelled approaches that banks have supervisory approval to use | RWA for portfolios where standardized approaches are used | Total actual RWA | RWA calculated using full standardized approach (1) |
| 1 | Sovereign | 4,893 | 1,330 | 6,223 | 5,347 |
| | Of which: categorized as MDB/PSE in SA | - | - | - | - |
| 2 | Banks and other financial institutions | 3,498 | 1,034 | 4,532 | 4,650 |
| 3 | Covered bonds | 2,927 | 333 | 3,260 | 5,902 |
| 4 | Equity | 278 | - | 278 | 472 |
| 5 | Purchased receivables | - | 1,541 | 1,541 | 1,541 |
| 6 | Corporates | 129,714 | 7,874 | 137,588 | 210,756 |
| | Of which: FIRB is applied | 35,541 | - | 35,541 | 39,981 |
| | Of which: AIRB is applied | 94,173 | - | 94,173 | 162,901 |
| 7 | Retail | 73,423 | 4,851 | 78,274 | 135,107 |
| | Of which: qualifying revolving retail | 20,773 | 2,984 | 23,757 | 28,211 |
| | Of which: other retail | 11,689 | 675 | 12,364 | 16,087 |
| | Of which: retail residential mortgages | 40,961 | 1,192 | 42,153 | 90,809 |
| 8 | Specialized lending | 13,675 | - | 13,675 | 30,638 |
| | Of which: income-producing real estate and high volatility commercial real estate | 78 | - | 78 | 79 |
| 9 | Others | 8,118 | - | 8,118 | 8,118 |
| 10 | Total | 224,910 | 24,047 | 248,957 | 397,881 |

($ millions)

| | | Q4/24 a | Q4/24 b | Q4/24 c | Q4/24 d |
|---|---|---|---|---|---|
| | | RWA for modelled approaches that banks have supervisory approval to use | RWA for portfolios where standardized approaches are used | Total actual RWA | RWA calculated using full standardized approach (1) |
| 1 | Sovereign | 4,803 | 1,293 | 6,096 | 5,004 |
| | Of which: categorized as MDB/PSE in SA | - | - | - | - |
| 2 | Banks and other financial institutions | 3,528 | 1,005 | 4,533 | 4,462 |
| 3 | Covered bonds | 2,645 | 328 | 2,973 | 6,853 |
| 4 | Equity | 289 | - | 289 | 458 |
| 5 | Purchased receivables | - | 1,427 | 1,427 | 1,427 |
| 6 | Corporates | 126,358 | 7,331 | 133,689 | 204,360 |
| | Of which: FIRB is applied | 35,177 | - | 35,177 | 39,564 |
| | Of which: AIRB is applied | 91,181 | - | 91,181 | 157,465 |
| 7 | Retail | 72,199 | 4,747 | 76,946 | 135,182 |
| | Of which: qualifying revolving retail | 19,749 | 2,981 | 22,730 | 27,450 |
| | Of which: other retail | 12,122 | 627 | 12,749 | 16,102 |
| | Of which: retail residential mortgages | 40,328 | 1,139 | 41,467 | 91,630 |
| 8 | Specialized lending | 12,900 | - | 12,900 | 29,043 |
| | Of which: income-producing real estate and high volatility commercial real estate | 90 | - | 90 | 100 |
| 9 | Others | 8,696 | - | 8,696 | 8,696 |
| 10 | Total | 219,284 | 23,822 | 243,106 | 391,023 |

($ millions)

| | | Q3/24 a | Q3/24 b | Q3/24 c | Q3/24 d |
|---|---|---|---|---|---|
| | | RWA for modelled approaches that banks have supervisory approval to use | RWA for portfolios where standardized approaches are used | Total actual RWA | RWA calculated using full standardized approach (1) |
| 1 | Sovereign | 222,198 | 22,725 | 244,923 | 393,063 |
| 2 | Counterparty credit risk | 8,173 | 744 | 8,917 | 22,446 |
| 3 | CVA | - | 3,082 | 3,082 | 3,082 |
| 4 | Securitization exposures in the banking book | 3,242 | 4,272 | 7,514 | 6,729 |
| 5 | Market risk | 11,112 | - | 11,112 | 11,112 |
| 6 | Operational risk | 45,763 | - | 45,763 | 45,763 |
| 7 | Residual RWA | 7,891 | - | 7,891 | 7,891 |
| 8 | Total | 233,613 | 95,589 | 329,202 | 490,086 |

## CMS2 – COMPARISON OF MODELLED AND STANDARDIZED RWA FOR CREDIT RISK AT ASSET CLASS LEVEL (continued)

($ millions)

| | | Q2/24 a | Q2/24 b | Q2/24 c | Q2/24 d |
|---|---|---|---|---|---|
| | | RWA for modelled approaches that banks have supervisory approval to use | RWA for portfolios where standardized approaches are used | Total actual RWA | RWA calculated using full standardized approach (1) |
| 1 | Credit risk (excluding counterparty credit risk) | 218,210 | 22,785 | 240,995 | 393,042 |
| 2 | Counterparty credit risk | 8,459 | 755 | 9,214 | 24,094 |
| 3 | CVA | - | 3,301 | 3,301 | 3,301 |
| 4 | Securitization exposures in the banking book | 3,864 | 3,579 | 7,443 | 6,070 |
| 5 | Market risk | 12,787 | - | 12,787 | 12,787 |
| 6 | Operational risk | 45,046 | - | 45,046 | 45,046 |
| 7 | Residual RWA | 7,728 | - | 7,728 | 7,728 |
| 8 | Total | 230,533 | 95,981 | 326,514 | 492,068 |

($ millions)

| | | Q1/24 a | Q1/24 b | Q1/24 c | Q1/24 d |
|---|---|---|---|---|---|
| | | RWA for modelled approaches that banks have supervisory approval to use | RWA for portfolios where standardized approaches are used | Total actual RWA | RWA calculated using full standardized approach (1) |
| 1 | Credit risk (excluding counterparty credit risk) | 212,503 | 21,502 | 234,005 | 385,847 |
| 2 | Counterparty credit risk | 7,623 | 710 | 8,333 | 22,227 |
| 3 | CVA | - | 3,579 | 3,579 | 3,579 |
| 4 | Securitization exposures in the banking book | 3,799 | 3,355 | 7,154 | 5,916 |
| 5 | Market risk | 11,634 | - | 11,634 | 11,634 |
| 6 | Operational risk | 44,347 | - | 44,347 | 44,347 |
| 7 | Residual RWA | 7,281 | - | 7,281 | 7,281 |
| 8 | Total | 223,925 | 92,408 | 316,333 | 480,831 |

(1) RWA calculated using full standardized approach (column (d)): Total RWA assuming the full standardized approach applied at asset class level. Disclosed numbers for each asset class are calculated purely for comparison purposes and do not represent requirements under the Basel framework.

## LI1: DIFFERENCES BETWEEN ACCOUNTING AND REGULATORY SCOPES OF CONSOLIDATION AND MAPPING OF FINANCIAL STATEMENT CATEGORIES WITH REGULATORY RISK CATEGORIES

($ millions)

| | | Q1/25 a | Q1/25 b | Q1/25 c | Q1/25 d | Q1/25 e | Q1/25 f |
|---|---|---|---|---|---|---|---|
| | | Carrying values as reported in published financial statements | Carrying values under scope of consolidation (2) | Subject to credit risk framework | Items subject to: Counterparty credit risk framework | Subject to the market risk framework | Not subject to capital requirements or subject to deduction from capital |
| **ASSETS** | | | | | | | |
| Cash and non-interest-bearing deposits with banks | | 13,530 | 13,530 | 13,530 | - | - | - |
| Interest-bearing deposits with banks | | 34,281 | 34,281 | 34,281 | - | - | - |
| Securities | | 273,041 | 272,784 (4) | 157,356 | 1,708 | 3,562 | 111,867 |
| Cash collateral on securities borrowed | | 18,609 | 18,609 | 18,609 | - | - | - |
| Securities purchased under resale agreements | | 86,143 | 86,143 | 60,702 | 1,968 | 23,473 | 457 |
| Loans (5) | | 568,119 | 568,119 (6) | 544,698 | 1,584 | 18,680 | 2,700 |
| Other | | | | | | | |
| Derivative instruments | | 38,572 | 38,572 (7) | 38,572 | - | - | 34,700 |
| Property and equipment | | 3,359 | 3,359 | 3,359 | - | - | - |
| Goodwill | | 5,635 | 5,635 | - | - | - | 5,635 |
| Software and other intangible assets | | 2,809 | 2,809 | - | - | - | 2,809 |
| Investments in equity-accounted associates and joint ventures | | 703 | 1,003 | 975 | - | - | 28 |
| Deferred tax assets | | 749 | 736 | 1,545 | - | - | (809) (8) |
| Other assets | | 36,914 | 36,866 | 21,566 | 9,773 | 96 | 4,003 | 1,428 |
| Total assets | | 88,741 | 88,980 | 27,445 | 48,345 | 96 | 38,703 | 9,091 |
| | 1,082,464 | 1,082,446 | 777,310 | 130,948 | 24,306 | 174,500 | 11,791 |
| **LIABILITIES** | | | | | | | |
| Deposits | | 258,666 | 258,666 | 258,666 | - | - | - |
| Personal | | 443,533 | 443,533 | - | 28,836 | 414,697 |
| Business and government | | 20,109 | - | - | 20,109 |
| Bank | | 59,868 | 59,868 | - | - | 59,868 |
| Secured borrowings | | 782,176 | 782,176 | 28,836 | 753,340 |
| Obligations related to securities sold short | | 20,778 | 20,778 | 20,269 | 509 |
| Cash collateral on securities lent | | 8,914 | 8,914 | - | - | 8,914 |
| Obligations related to securities sold under repurchase agreements | | 127,636 | 127,636 | - | - | 127,636 |
| Other | | | | | | | |
| Derivative instruments | | 44,902 | 44,902 (7) | 44,902 | - | - | 41,777 |
| Deferred tax liability | | 50 | 50 | - | - | 50 |
| Other liabilities (5) | | 28,879 | 28,861 | - | 3,999 | 24,862 |
| Subordinated indebtedness | | 73,831 | 73,813 | 44,902 | 45,776 | 24,912 |
| | 7,498 | 7,498 | - | - | 7,498 |
| Total liabilities | | 1,020,833 | 1,020,815 | 181,452 | 45,776 | 94,881 | 786,259 |

(1) Amounts are included in more than one column if they are subject to more than one risk framework.
(2) CIBC's insurance subsidiaries CIBC Cayman Reinsurance Limited (CIBC Cayman Re) and CIBC Life Insurance Company Limited (CIBC Life) are excluded from the scope of regulatory consolidation. Refer to table CC2 for further information.
(3) Excludes securitization exposures in the trading book, which are subject to market risk.
(4) Non-trading securities are subject to credit risk, except for certain asset-backed securities that are risk-weighted under the securitization framework. Securities pledged as initial margin or as contributions to default funds of central counterparties are subject to both credit risk and counterparty credit risk.
(5) Includes customers' liability under acceptances of \$10 million in business and government loans and acceptances of \$10 million in other liabilities.
(6) Non-trading loans are subject to credit risk only, with the exception of securitization-related loans, which are risk-weighted under the securitization framework.
(7) Trading derivatives are subject to both counterparty credit risk and market risk.
(8) Includes deferred tax liabilities related to software and other intangible assets, defined benefit pension assets, and goodwill that are offset against the amounts deducted from regulatory capital.

## LI2: MAIN SOURCES OF DIFFERENCES BETWEEN REGULATORY EXPOSURE AMOUNTS AND CARRYING VALUES IN FINANCIAL STATEMENTS

($ millions)

| | | Q1/25 a | Q1/25 b | Q1/25 c | Q1/25 d | Q1/25 e | Q1/25 f |
|---|---|---|---|---|---|---|---|
| | | Total (1) | Credit risk framework (2) | Securitization framework | Counterparty credit risk framework | Market risk framework | |
| 1 | Asset carrying value amount under scope of regulatory consolidation (as per template LI1) | 1,070,655 | 777,310 | 24,306 | 130,948 | 174,500 | - |
| 2 | Liabilities carrying value amount under regulatory scope of consolidation (as per template LI1) | 234,556 | 181,452 | - | 94,881 | - | - |
| 3 | Total net amount under regulatory scope of consolidation | 836,099 | 777,310 | 24,306 | (50,504) | 79,619 | - |
| 4 | Off-balance sheet amounts (3) | 546,089 | 197,342 | 33,094 | 315,653 | - | - |
| 5 | Differences in valuations | 785 | 785 (4) | - | - | - | - |
| 6 | Differences due to different netting rules, other than those already included in row 3 | 31,593 | 31,593 | - | - | - | - |
| 7 | Differences due to consideration of provisions (5) | 3,911 | 3,911 | - | - | - | - |
| 8 | Differences due to prudential filters | - | - | - | - | - | - |
| 9 | Gross-up for SFTs (6) | 273,100 | - | - | - | - | - |
| 10 | Differences due to inclusion of potential future exposure and alpha multiplier in derivative EAD | 4,245 | - | - | - | - | - |
| 11 | Collateral (7) | (511,189) | - | (1,459) | - | - | - |
| 12 | Other | (1,459) | - | - | - | - | - |
| 13 | Exposure amounts considered for regulatory purposes | 1,183,174 | 977,889 | 57,400 | 62,898 | 79,619 | - |

(1) The total in column a will not equal the sum of columns b through e to the extent that items are subject to regulatory capital charges in more than one framework.
(2) Includes exposures of \$946 million relating to equity investments in funds.
(3) Comprises off-balance sheet exposures for undrawn commitments, repo-style transactions, derivatives, third-party assets relating to our prime brokerage business and other off-balance sheet items.
(4) Includes basis adjustments for fair value hedges that impact the accounting carrying values but do not impact exposure amounts considered for regulatory purposes.
(5) The accounting carrying value for loans is net of the full allowance for credit losses. For regulatory purposes only allowances on impaired (stage 3) loans that are risk-weighted under the SA are netted against the exposures.
(6) Liabilities for repo-style transactions represent regulatory exposures under the counterparty credit risk framework. As these liabilities are deducted from the carrying value of assets in line 2, a gross-up is required to arrive at the exposure amount considered for regulatory purposes.
(7) Primarily comprises collateral for repo-style transactions, including those settled through qualified central counterparties (QCCPs).

## PV1: PRUDENT VALUATION ADJUSTMENTS (PVAs)

($ millions)

| | | Q1/25 a | Q1/25 b | Q1/25 c | Q1/25 d | Q1/25 e | Q1/25 f | Q1/25 g | Q1/25 h |
|---|---|---|---|---|---|---|---|---|---|
| | | Equity | Interest rates | Foreign exchange | Credit Commodities | Total trading book | Of which: in the banking book |
| 1 | Closeout uncertainty, of which: | - | - | - | 18 | - | 18 | 18 | 18 |
| 2 | Mid-market value | - | - | - | - | - | - | - | - |
| 3 | Closeout cost | - | - | - | - | - | - | - | - |
| 4 | Concentration | - | - | - | 18 | - | 18 | 18 | 18 |
| 5 | Early termination | - | - | - | - | - | - | - | - |
| 6 | Model risk | - | - | - | - | - | - | - | - |
| 7 | Operational risk | - | - | - | - | - | - | - | - |
| 8 | Investing and funding costs | - | - | - | - | - | - | - | - |
| 9 | Unearned credit spreads | - | - | - | - | - | - | - | - |
| 10 | Future administrative costs | - | - | - | - | - | - | - | - |
| 11 | Other | - | - | - | - | - | - | - | - |
| 12 | Total adjustments | - | - | - | 18 | - | 18 | 18 | 18 |

($ millions)

| | | Q4/24 a | Q4/24 b | Q4/24 c | Q4/24 d | Q4/24 e | Q4/24 f | Q4/24 g | Q4/24 h |
|---|---|---|---|---|---|---|---|---|---|
| | | Equity | Interest rates | Foreign exchange | Credit Commodities | Total trading book | Of which: in the banking book |
| 1 | Closeout uncertainty, of which: | - | - | - | 4 | - | 4 | 4 | 4 |
| 2 | Mid-market value | - | - | - | - | - | - | - | - |
| 3 | Closeout cost | - | - | - | - | - | - | - | - |
| 4 | Concentration | - | - | - | 4 | - | 4 | 4 | 4 |
| 5 | Early termination | - | - | - | - | - | - | - | - |
| 6 | Model risk | - | - | - | - | - | - | - | - |
| 7 | Operational risk | - | - | - | - | - | - | - | - |
| 8 | Investing and funding costs | - | - | - | - | - | - | - | - |
| 9 | Unearned credit spreads | - | - | - | - | - | - | - | - |
| 10 | Future administrative costs | - | - | - | - | - | - | - | - |
| 11 | Other | - | - | - | - | - | - | - | - |
| 12 | Total adjustments | - | - | - | 4 | - | 4 | 4 | 4 |

($ millions)

| | | Q3/24 a | Q3/24 b | Q3/24 c | Q3/24 d | Q3/24 e | Q3/24 f | Q3/24 g | Q3/24 h |
|---|---|---|---|---|---|---|---|---|---|
| | | Equity | Interest rates | Foreign exchange | Credit Commodities | Total trading book | Of which: in the banking book |
| 1 | Closeout uncertainty, of which: | - | - | - | 3 | - | 3 | 3 | 3 |
| 2 | Mid-market value | - | - | - | - | - | - | - | - |
| 3 | Closeout cost | - | - | - | - | - | - | - | - |
| 4 | Concentration | - | - | - | 3 | - | 3 | 3 | 3 |
| 5 | Early termination | - | - | - | - | - | - | - | - |
| 6 | Model risk | - | - | - | - | - | - | - | - |
| 7 | Operational risk | - | - | - | - | - | - | - | - |
| 8 | Investing and funding costs | - | - | - | - | - | - | - | - |
| 9 | Unearned credit spreads | - | - | - | - | - | - | - | - |
| 10 | Future administrative costs | - | - | - | - | - | - | - | - |
| 11 | Other | - | - | - | - | - | - | - | - |
| 12 | Total adjustments | - | - | - | 3 | - | 3 | 3 | 3 |

## PV1: PRUDENT VALUATION ADJUSTMENTS (PVAs) (continued)

($ millions)

| | | Q2/24 a | Q2/24 b | Q2/24 c | Q2/24 d | Q2/24 e | Q2/24 f | Q2/24 g | Q2/24 h |
|---|---|---|---|---|---|---|---|---|---|
| | | Equity | Interest rates | Foreign exchange | Credit Commodities | Total trading book | Of which: in the banking book |
| 1 | Closeout uncertainty, of which: | - | - | - | 5 | - | 5 | 5 | 5 |
| 2 | Mid-market value | - | - | - | - | - | - | - | - |
| 3 | Closeout cost | - | - | - | - | - | - | - | - |
| 4 | Concentration | - | - | - | 5 | - | 5 | 5 | 5 |
| 5 | Early termination | - | - | - | - | - | - | - | - |
| 6 | Model risk | - | - | - | - | - | - | - | - |
| 7 | Operational risk | - | - | - | - | - | - | - | - |
| 8 | Investing and funding costs | - | - | - | - | - | - | - | - |
| 9 | Unearned credit spreads | - | - | - | - | - | - | - | - |
| 10 | Future administrative costs | - | - | - | - | - | - | - | - |
| 11 | Other | - | - | - | - | - | - | - | - |
| 12 | Total adjustments | - | - | - | 5 | - | 5 | 5 | 5 |

($ millions)

| | | Q1/24 a | Q1/24 b | Q1/24 c | Q1/24 d | Q1/24 e | Q1/24 f | Q1/24 g | Q1/24 h |
|---|---|---|---|---|---|---|---|---|---|
| | | Equity | Interest rates | Foreign exchange | Credit Commodities | Total trading book | Of which: in the banking book |
| 1 | Closeout uncertainty, of which: | - | - | - | 4 | - | 4 | 4 | 4 |
| 2 | Mid-market value | - | - | - | - | - | - | - | - |
| 3 | Closeout cost | - | - | - | - | - | - | - | - |
| 4 | Concentration | - | - | - | 4 | - | 4 | 4 | 4 |
| 5 | Early termination | - | - | - | - | - | - | - | - |
| 6 | Model risk | - | - | - | - | - | - | - | - |
| 7 | Operational risk | - | - | - | - | - | - | - | - |
| 8 | Investing and funding costs | - | - | - | - | - | - | - | - |
| 9 | Unearned credit spreads | - | - | - | - | - | - | - | - |
| 10 | Future administrative costs | - | - | - | - | - | - | - | - |
| 11 | Other | - | - | - | - | - | - | - | - |
| 12 | Total adjustments | - | - | - | 4 | - | 4 | 4 | 4 |

## CC1: COMPOSITION OF REGULATORY CAPITAL

Row | ($ millions) | Q1/25 | Q4/24 | Q3/24 | Q2/24 | Q1/24 | Cross-reference (1) |
|---|---|---|---|---|---|---|---|
| **Common Equity Tier 1 (CET1) capital: instruments and reserves** | | | | | | | |
| 1 | Directly issued qualifying common share capital plus related stock surplus | 17,193 | 17,170 | 17,047 | 16,927 | 16,555 | A+B |
| 2 | Retained earnings | 34,366 | 33,471 | 32,844 | 31,990 | 31,162 | C |
| 3 | Accumulated other comprehensive income (AOCI) (and other reserves) | 4,442 | 3,148 | 2,689 | 1,394 | 1,449 | D |
| 4 | Directly issued capital subject to phase out from CET1 (only applicable to non-joint stock companies) | n/a | 127 | 119 | n/a | n/a | E |
| 5 | Common share capital issued by subsidiaries and held by third parties (amount allowed in group CET1) | | | 105 | 107 | 104 | |
| 6 | CET1 capital before regulatory adjustments | 56,128 | 53,908 | 52,685 | 50,418 | 49,270 | F+G+H |
| **CET1 capital: regulatory adjustments** | | | | | | | |
| 7 | Prudential valuation adjustments | 5,552 | 5,360 | 5,324 | 5,312 | 5,211 | See footnote 2 |
| 8 | Goodwill (net of related tax liabilities) | 2,432 | 2,456 | 2,350 | 2,372 | 2,384 | I+J+AI |
| 9 | Other intangibles other than mortgage-servicing rights (net of related tax liabilities) | 21 | 15 | 16 | 11 | 11 | K |
| 10 | Deferred tax assets excluding those arising from temporary differences (net of related tax liabilities) | 509 | 260 | (737) | (271) | L |
| 11 | Cash flow hedge reserve | 1 | 17 | (15) | 30 | See footnote 2 | |
| 12 | Shortfall of provisions to expected losses (3) | 1,086 | 1,045 | 928 | 742 | 739 | M+AH |
| 13 | Securitization gain on sale | 5 | 2 | 3 | 2 | | N+O |
| 14 | Gains and losses due to changes in own credit risk on fair valued liabilities | | | | | | See footnote 2 |
| 15 | Defined benefit pension fund net assets (net of related tax liabilities) | | | | | | |
| 16 | Investments in own shares (if not already netted off paid-in capital on reported balance sheet) | | | | | | |
| 17 | Reciprocal cross holdings in common equity | | | | | | |
| 18 | Non-significant investments in the capital of banking, financial and insurance entities, net of eligible short positions (amount above 10% threshold) | | | | | | P+Q |
| 19 | Significant investments in the common stock of banking, financial and insurance entities that are outside the scope of regulatory consolidation, net of eligible short positions (amount above 10% threshold) | | | | | | |
| 20 | Mortgage servicing rights (amount above 10% threshold) | | | | | | |
| 21 | Deferred tax assets arising from temporary differences (amount above 10% threshold, net of related tax liability) | | | | | | R+S |
| 22 | Amount exceeding the 15% threshold | | | | | | T |
| 23 | of which: significant investments in the common stock of financials | | | | | | |
| 24 | of which: mortgage servicing rights | | | | | | |
| 25 | of which: deferred tax assets arising from temporary differences | | | | | | |
| 26 | Other deductions or regulatory adjustments to CET1 as determined by OSFI | | | | | | |
| 27 | Regulatory adjustments applied to CET1 due to insufficient Additional Tier 1 (AT1) and Tier 2 (T2) to cover deductions | 9,915 | 9,392 | 8,901 | 7,690 | 8,110 | |
| 28 | Total regulatory adjustments to CET1 | 46,213 | 44,516 | 43,784 | 42,728 | 41,160 | |
| 29 | CET1 capital | | | | | | |
| **AT1 capital: instruments** | | 5,341 | 4,946 | 4,949 | 5,098 | 4,925 | U |
| 30 | Directly issued qualifying AT1 instruments plus related stock surplus (4) | 5,341 | 4,946 | 4,949 | 5,098 | 4,925 | |
| 31 | of which: classified as equity under applicable accounting standards | | | | | | |
| 32 | of which: classified as liabilities under applicable accounting standards | | | | | | |
| 33 | Directly issued capital instruments subject to phase out from AT1 | | | | | | |
| 34 | AT1 instruments (and CET1 instruments not included in row 5) issued by subsidiaries and held by third parties (amount allowed in group AT1) | 20 | 19 | 18 | 19 | 18 | V |
| 35 | of which: instruments issued by subsidiaries subject to phase out | | | | | | |
| 36 | AT1 capital before regulatory adjustments | 5,361 | 4,965 | 4,967 | 5,117 | 4,943 | |
| **AT1 capital: regulatory adjustments** | | | | | | | |
| 37 | Investments in own AT1 instruments | | | | | | |
| 38 | Reciprocal cross holdings in AT1 instruments | | | | | | |
| 39 | Other deductions from Tier 1 (T1) capital as determined by OSFI | | | | | | |
| 40 | Regulatory adjustments applied to AT1 due to insufficient T2 to cover deductions | | | | | | |
| 41 | Total regulatory adjustments to AT1 capital | | | | | | |
| 42 | AT1 capital | 5,361 | 4,965 | 4,967 | 5,117 | 4,943 | |
| 43 | T1 capital (T1 = CET1 + AT1) | 51,574 | 49,481 | 48,751 | 47,845 | 46,103 | |
| **T2 capital: instruments and provisions** | | | | | | | |
| 44 | Directly issued qualifying T2 instruments plus related stock surplus (5) | 7,000 | 6,920 | 6,889 | 7,235 | 7,278 | W |
| 45 | Directly issued capital instruments subject to phase out from T2 | 19 | 17 | 24 | 25 | 24 | X |
| 46 | T2 instruments (and CET1 and AT1 instruments not included in rows 5 or 34) issued by subsidiaries and held by third parties (amount allowed in group Tier 2) | | | | | | |
| 47 | of which: instruments issued by subsidiaries subject to phase out | | | | | | |
| 48 | Other | 521 | 391 | 480 | 373 | 374 | Y+Z |
| 49 | General allowances | 7,540 | 7,328 | 7,394 | 7,633 | 7,676 | |
| 50 | T2 capital before regulatory adjustments | 59,114 | 56,809 | 56,145 | 55,478 | 53,779 | |
| 51 | Total capital (TC = T1 + T2) | 341,930 | 333,502 | 329,202 | 326,514 | 316,333 | |
| 52 | Total RWA | | | | | | |

## CC1: COMPOSITION OF REGULATORY CAPITAL (continued)

Row | ($ millions) | Q1/25 | Q4/24 | Q3/24 | Q2/24 | Q1/24 | Cross-reference (1) |
|---|---|---|---|---|---|---|---|
| **T2 capital: instruments and provisions (continued)** | | | | | | | |
| 53 | Investments in own T2 instruments | | | | | | |
| 54 | Reciprocal cross holdings in T2 instruments and other TLAC-eligible instruments | | | | | | |
| 55 | Non-significant investments in the capital of banking, financial and insurance entities and other TLAC-eligible instruments issued by G-SIBs and Canadian D-SIBs that are outside the scope of regulatory consolidation, where the institution does not own more than 10% of the issued common share capital of the entity (amount above 10% threshold) | - | - | - | - | - | |
| 55a | Non-significant investments in the other TLAC-eligible instruments issued by G-SIBs and Canadian D-SIBs, where the institution does not own more than 10% of the issued common share capital of the entity: amount previously designated for the 5% threshold but that no longer meets the conditions | - | - | - | - | - | |
| 56 | Significant investments in the capital of banking, financial and insurance entities and Other TLAC-eligible instruments issued by G-SIBs and Canadian D-SIBs that are outside the scope of regulatory consolidation | - | - | - | - | - | |
| 57 | Other deductions from T2 capital | - | - | - | - | - | |
| 58 | Total regulatory adjustments to T2 capital | 7,540 | 7,328 | 7,394 | 7,633 | 7,676 | AE+AF+AG |
| 59 | T2 capital | 59,114 | 56,809 | 56,145 | 55,478 | 53,779 | |
| 60 | Total capital (TC = T1 + T2) | 341,930 | 333,502 | 329,202 | 326,514 | 316,333 | |
| 61 | Total RWA | | | | | | |
| **Capital ratios** | | | | | | | |
| 62 | CET1 (as a percentage of RWA) | 13.5% | 13.3% | 13.3% | 13.1% | 13.0% | |
| 63 | T1 (as a percentage of RWA) | 15.1% | 14.8% | 14.8% | 14.7% | 14.6% | |
| 64 | Total capital (as a percentage of RWA) | 17.3% | 17.0% | 17.1% | 17.0% | 17.0% | |
| 65 | Buffer (minimum CET1 requirement plus capital conservation buffer plus G-SIB buffer plus D-SIB buffer expressed as a percentage of RWA) | 8.0% | 8.0% | 8.0% | 8.0% | 8.0% | |
| 66 | of which: capital conservation buffer | 2.5% | 2.5% | 2.5% | 2.5% | 2.5% | |
| 67 | of which: bank specific countercyclical buffer (6) | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 67a | of which: G-SIB buffer | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 67b | of which: D-SIB buffer | 1.0% | 1.0% | 1.0% | 1.0% | 1.0% | |
| 68 | CET1 available to meet buffers (as percentage of RWA) (7) | 9.0% | 8.8% | 8.8% | 8.6% | 8.5% | |
| **OSFI target (minimum + capital conservation buffer + D-SIB buffer (if applicable)) (8)** | | | | | | | |
| 69 | CET1 target ratio | 8.0% | 8.0% | 8.0% | 8.0% | 8.0% | |
| 70 | T1 capital target ratio | 9.5% | 9.5% | 9.5% | 9.5% | 9.5% | |
| 71 | Total capital target ratio | 11.5% | 11.5% | 11.5% | 11.5% | 11.5% | |
| **Amounts below the thresholds for deduction (before risk-weighting)** | | | | | | | |
| 72 | Non-significant investments in the capital and other TLAC-eligible instruments of other financial entities | 438 | 314 | 434 | 1,202 | 530 | see footnote 9 |
| 73 | Significant investments in the common stock of financials | 860 | 932 | 870 | 847 | 819 | AB+AC+AD |
| 74 | Mortgage servicing rights (net of related tax liability) | | | | | | |
| 75 | Deferred tax assets arising from temporary differences (net of related tax liabilities) | 1,545 | 1,611 | 1,392 | 1,377 | 1,275 | AA |
| **Applicable caps on the inclusion of allowances in T2** | | | | | | | |
| 76 | Allowances eligible for inclusion in T2 in respect of exposures subject to SA (prior to application of cap) | 262 | 249 | 255 | 215 | 214 | Y |
| 77 | Cap on inclusion of allowances in T2 under SA | 514 | 516 | 482 | 477 | 455 | |
| 78 | Allowances eligible for inclusion in T2 in respect of exposures subject to IRBA (prior to application of cap) | 259 | 142 | 225 | 158 | 160 | Z |
| 79 | Cap on inclusion of allowances in T2 under IRBA | 1,446 | 1,399 | 1,402 | 1,383 | 1,341 | |

(1) Cross-referenced to the consolidated balance sheet, refer to table CC2.
(2) Not recorded on the consolidated balance sheet.
(3) Provisions in the shortfall calculation represent stage 1, 2, and 3 allowances for credit losses.
(4) Comprises non-viability contingent capital (NVCC) preferred shares and limited recourse capital notes (LRCN).
(5) Comprises certain debentures which qualify as NVCC.
(6) Bank specific countercyclical buffer requirement of 0.03% in Q1/25 (Q4/24: 0.03%) is the amount which is determined based on our weighted average private sector exposures in jurisdictions identified by the BCBS.
(7) Calculated by row 61 above minus the CET 1 regulatory minimum requirement of 4.5%.
(8) The OSFI target ratios above represent the Pillar 1 capital requirements, which do not include the DSB that OSFI requires D-SIBs to hold. The DSB is currently at 3.5%, increased from 3.0% effective November 1, 2023.
(9) Synthetic positions not recorded on the consolidated balance sheet.
n/a Not applicable.

## CC2: RECONCILIATION OF REGULATORY CAPITAL TO BALANCE SHEET

($ millions)

| Assets | Balance sheet as in report to shareholders | Q1/25 Balance sheet as in the regulatory scope of consolidation (1) | Cross reference to capital schedule (2) |
|---|---|---|---|
| Cash and non-interest-bearing deposits with banks | 13,530 | 13,530 | |
| Interest-bearing deposits with banks | 34,281 | 34,281 | |
| Securities | 273,041 | 272,784 | AD |
| Significant investments in capital of other financial institutions not exceeding regulatory thresholds | - | 79 | AE |
| Non-significant investments in capital of other financial institutions not exceeding regulatory thresholds | - | - | |
| Significant investments in capital of non-financial institutions | - | 272,705 | |
| Other securities | 18,609 | 18,609 | |
| Cash collateral on securities borrowed | 86,143 | 86,143 | |
| Securities purchased under resale agreements | 572,223 | 572,223 | |
| Loans (3) | (4,104) | (4,104) | (262) | Y |
| Allowance for credit losses | | | |
| General allowance reflected in T2 capital | | (259) | Z |
| Excess in allowance over expected losses reflected in T2 capital | | (3,583) | |
| Allowances not reflected in regulatory capital | 38,572 | 38,572 | |
| Derivative instruments | 3,359 | 3,359 | |
| Property and equipment | 5,635 | 5,635 | F |
| Goodwill | 2,809 | 2,809 | |
| Software and other intangible assets | 703 | 1,003 | P |
| Investments in equity-accounted associates and joint ventures | 749 | 736 | R |
| Significant investments in capital of other financial institutions exceeding regulatory thresholds (10% of CET1) | | 560 | AB |
| Significant investments in capital of other financial institutions exceeding regulatory thresholds (15% basket of CET1) | | 10 | G |
| Significant investments in capital of other financial institutions not exceeding regulatory thresholds | | 18 | AI |
| Significant investments in capital of other financial institutions related to goodwill | | 25 | Q |
| Significant investments in capital of other financial institutions related to intangibles | | | S |
| Significant investments in capital of non-financial institutions | | 300 | AC |
| Investment in deconsolidated subsidiaries exceeding regulatory thresholds (10% of CET1) | | 36 | AG |
| Investment in deconsolidated subsidiaries exceeding regulatory thresholds (15% basket of CET1) | | 54 | |
| Investment in deconsolidated subsidiaries not exceeding regulatory thresholds | 749 | 736 | 21 | K |
| Non-significant investments in capital of other financial institutions not exceeding regulatory thresholds | | 1,545 | AA | T |
| Non-significant investments in capital of non-financial institutions | 1,428 | 1,428 | (93) | H |
| Deferred tax assets | 35,486 | 35,438 | (395) | J |
| Deferred tax assets excluding those arising from temporary differences | | | (342) | O |
| Deferred tax assets arising from temporary differences exceeding regulatory thresholds (15% basket of CET1) | | | | |
| Deferred tax assets arising from temporary differences not exceeding regulatory thresholds | 1,428 | 1,428 | N |
| Deferred tax liabilities related to goodwill | 35,438 | 35,438 | | |
| Deferred tax liabilities related to software and other intangible assets | | | | |
| Deferred tax liabilities related to defined benefit pension fund net assets | | | | |
| Other assets | | | | |
| Defined benefit pension fund net assets | | | | |
| Other | | | | |
| Non-significant investments in capital of other financial institutions not exceeding regulatory thresholds | | | | |
| Other | | | | |
| Total assets | 1,082,464 | 1,082,446 | | | |

## CC2: RECONCILIATION OF REGULATORY CAPITAL TO BALANCE SHEET (continued)

Liabilities | Balance sheet as in report to shareholders | Q1/25 Balance sheet as in the regulatory scope of consolidation (1) | Of which | Cross reference to capital schedule (2) |
|---|---|---|---|---|
| Deposits | 782,176 | 782,176 | | |
| Obligations related to securities sold short | 20,778 | 20,778 | | |
| Cash collateral on securities lent | 8,914 | 8,914 | | |
| Obligations related to securities sold under repurchase agreements | 127,636 | 127,636 | | |
| Derivative instruments | 44,902 | 44,902 | | |
| Deferred tax liabilities | 50 | 50 | | |
| Other liabilities (3) | 28,879 | 28,861 | | |
| Subordinated indebtedness | 7,498 | 7,498 | 7,000 | W |
| Subordinated indebtedness allowed for inclusion in T2 capital | | 498 | | |
| Subordinated indebtedness not allowed for T2 capital | 1,020,833 | 1,020,815 | | |
| **Total liabilities** | | | | |
| **Equity** | | | | |
| Preferred shares and other equity instruments | 5,341 | 5,341 | 5,341 | U |
| Preferred shares and other equity instruments allowed for inclusion into additional T1 capital | | | | |
| Common shares | 17,027 | 17,027 | | A |
| Common shares - treasury positions | | 5 | | |
| Common shares | 166 | 166 | 17,022 | B |
| Contributed surplus | 34,366 | 34,366 | | C |
| Retained earnings | | 92 | M |
| Gains and losses due to changes in own credit risk on fair valued liabilities | 34,274 | | | |
| Other retained earnings | 4,442 | 4,442 | D |
| AOCI | | 800 | L |
| Cash flow hedges | | (91) | AH |
| Net fair value gains (losses) arising from changes in institution's own credit risk | 3,733 | | | |
| Other | 289 | 289 | 127 | E |
| Non-controlling interests | | | | |
| Portion allowed for inclusion into CET1 | | 20 | V |
| Portion allowed for inclusion into additional T1 capital | | 19 | X |
| Portion allowed for inclusion into T2 capital | | 123 | | |
| Portion not allowed for regulatory capital | 61,631 | | | |
| Total equity | 1,082,464 | 1,082,446 | | |
| **Total liabilities and equity** | | | | |

(1) CIBC Cayman Re and CIBC Life are excluded from the regulatory scope of consolidation. CIBC Cayman Re provides life and health reinsurance to Canadian insurance and international reinsurance companies. CIBC Life is primarily involved in direct underwriting of life insurance products and has assumed a closed creditor product block of business from a Canadian underwriter; current policies in-force include accidental death, hospital accident, hospital cash benefit plans, critical accident plan, accident recovery plan, term life, and creditor life and disability insurance products. As at Q1/25, on a legal entity basis, CIBC Cayman Re had \$199 million in assets and \$171 million in equity, and CIBC Life had \$167 million in assets and \$129 million in equity.
(2) Refer to table CC1.
(3) Includes customers' liability under acceptances of \$10 million in business and government loans and acceptances of \$10 million in other liabilities.

## CHANGES IN REGULATORY CAPITAL

($ millions)

| Row | Q1/25 | Q4/24 | Q3/24 | Q2/24 | Q1/24 |
|---|---|---|---|---|---|
| **CET1 capital** | | | | | |
| 1 | Opening amount | 44,516 | 43,784 | 42,728 | 41,160 | 40,327 |
| 2 | Shares issued in lieu of cash dividends (add back) | 46 | 45 | 299 | 308 |
| 3 | Other issue of common shares | 77 | 136 | 58 | 68 | 59 |
| 4 | Redeemed capital | - | - | - | - | - |
| 5 | Purchase of common shares for cancellation | (63) | (90) | - | - | - |
| 6 | Premium on purchase of common shares for cancellation | (257) | (329) | - | - | - |
| 7 | Dividends and distributions | (1,002) | (922) | (912) | (905) | (906) |
| 8 | Net income attributable to equity shareholders | 2,163 | 1,874 | 1,786 | 1,739 | 1,716 |
| **Change in AOCI balances** | | | | | |
| 9 | Currency translation differences | 882 | 140 | 50 | 465 | (641) |
| 10 | Securities measured at fair value through other comprehensive income (FVOCI) | 104 | (55) | 18 | (10) | 149 |
| 11 | Cash flow hedges (1) | 291 | 250 | 996 | (466) | 755 |
| 12 | Fair value change of fair value option liabilities attributable to changes in credit risk (2) | (19) | 59 | (57) | (199) |
| 13 | Post-employment defined benefit plans | 19 | 143 | 172 | 13 | (78) |
| 14 | Removal of own credit spread (net of tax) | 16 | (32) | 45 | 285 |
| 15 | Goodwill and other intangible assets (deduction, net of related tax liabilities) | (168) | (142) | 10 | (89) | 133 |
| 16 | Shortfall of allowance to expected losses | | | | | |
| | Other, including regulatory adjustments | | | | | |
| 17 | Deferred tax assets that rely on future profitability (excluding those arising from temporary differences) | (6) | 1 | (5) | (2) |
| 18 | Defined benefit pension fund net assets | (41) | (117) | (186) | (3) | 54 |
| 19 | Significant investments in financial institutions (amount above 10% threshold) | | | | | |
| 20 | Amount exceeding 15% threshold | | | | | |
| 21 | Prudential valuation adjustments | (286) | (199) | (1,005) | 470 | (801) |
| 22 | Other (1)(2) | 46,213 | 44,516 | 43,784 | 42,728 | 41,160 |
| **AT1 capital** | | | | | | |
| 23 | Opening amount | 4,965 | 4,967 | 5,117 | 4,943 |
| 24 | AT1 eligible capital issues | 693 | 500 | (325) |
| 25 | Redeemed capital | (300) | (650) | |
| 26 | Impact of the cap on inclusion for instruments subject to phase out | 3 | (2) | (1) | |
| 27 | Other, including regulatory adjustments | 5,361 | 4,965 | 4,967 | 5,117 | 4,943 |
| 28 | Closing amount | 51,574 | 49,481 | 48,751 | 47,845 | 46,103 |
| **T2 capital** | | | | | | |
| 29 | Opening amount | 7,328 | 7,394 | 7,633 | 7,676 |
| 30 | New T2 eligible capital issues | 1,000 | 1,250 |
| 31 | Redeemed capital | (1,500) | | | |
| 32 | Amortization adjustments | | | | | |
| 33 | Impact of the cap on inclusion for instruments subject to phase out | 212 | 261 | (43) | (423) |
| 34 | Other, including regulatory adjustments | 7,540 | 7,328 | 7,394 | 7,633 | 7,676 |
| 35 | Closing amount | 59,114 | 56,809 | 56,145 | 55,478 | 53,779 |
| 36 | Total capital | | | | | |

(1) Net change in cash flow hedges is included in Line 11 then derecognized in Line 22.
(2) Q1/24 included a reduction to retained earnings related to the adoption of IFRS 17.

## TLAC1: TLAC COMPOSITION (AT RESOLUTION GROUP LEVEL)

($ millions)

| | | Q1/25 | Q4/24 | Q3/24 | Q2/24 | Q1/24 |
|---|---|---|---|---|---|---|
| **Regulatory capital elements of TLAC and adjustments** | | | | | | |
| 1 | CET1 capital | 46,213 | 44,516 | 43,784 | 42,728 | 41,160 |
| 2 | AT1 capital before TLAC adjustments | 5,361 | 4,965 | 4,967 | 5,117 | 4,943 |
| 3 | AT1 ineligible as TLAC as issued out of subsidiaries to third parties | - | - | - | - | - |
| 4 | Other adjustments | - | - | - | - | - |
| 5 | AT1 instruments eligible under the TLAC framework | 5,361 | 4,965 | 4,967 | 5,117 | 4,943 |
| 6 | T2 capital before TLAC adjustments | 7,540 | 7,328 | 7,394 | 7,633 | 7,676 |
| 7 | Amortized portion of T2 instruments where remaining maturity > 1 year | - | - | - | - | - |
| 8 | T2 capital ineligible as TLAC as issued out of subsidiaries to third parties | - | - | - | - | - |
| 9 | Other adjustments | - | - | - | - | - |
| 10 | T2 instruments eligible under the TLAC framework | 7,540 | 7,328 | 7,394 | 7,633 | 7,676 |
| 11 | TLAC arising from regulatory capital | 59,114 | 56,809 | 56,145 | 55,478 | 53,779 |
| **Non-regulatory capital elements of TLAC** | | | | | | |
| 12 | External TLAC instruments issued directly by the bank and subordinated to excluded liabilities | - | - | - | - | - |
| 13 | External TLAC instruments issued directly by the bank which are not subordinated to excluded liabilities but meet all other TLAC term sheet requirements | 48,628 | 44,376 | 43,042 | 40,437 | 46,141 |
| 14 | Of which: amount eligible as TLAC after application of the caps | - | - | - | - | - |
| 15 | External TLAC instruments issued by funding vehicles prior to January 1, 2022 | - | - | - | - | - |
| 16 | Eligible ex ante commitments to recapitalize a G-SIB in resolution | - | - | - | - | - |
| 17 | TLAC arising from non-regulatory capital instruments before adjustments | 48,628 | 44,376 | 43,042 | 40,437 | 46,141 |
| **Non-regulatory capital elements of TLAC: adjustments** | | | | | | |
| 18 | TLAC before deductions | 107,742 | 101,185 | 99,187 | 95,915 | 99,920 |
| 19 | Deductions of exposures between multiple point of entry resolution groups that correspond to items eligible for TLAC (not applicable to special purpose entities (SPEs) G-SIBs and D-SIBs) | n/a | n/a | n/a | n/a | n/a |
| 20 | Deduction of investments in own other TLAC liabilities | (209) | (123) | (37) | (25) | (108) |
| 21 | Other adjustments to TLAC | - | - | - | - | - |
| 22 | TLAC available after deductions | 107,533 | 101,062 | 99,150 | 95,890 | 99,812 |
| **RWA and leverage exposure measure for TLAC purposes** | | | | | | |
| 23 | Total RWA adjusted as permitted under the TLAC regime | 341,930 | 333,502 | 329,202 | 326,514 | 316,333 |
| 24 | Leverage exposure measure | 1,205,520 | 1,155,432 | 1,133,983 | 1,112,411 | 1,080,906 |
| **TLAC ratios and buffers (1)** | | | | | | |
| 25 | TLAC Ratio (as a percentage of RWA adjusted as permitted under the TLAC regime) (%) | 31.4% | 30.3% | 30.1% | 29.4% | 31.6% |
| 26 | TLAC Leverage Ratio (as a percentage of leverage exposure) (%) | 8.9% | 8.7% | 8.7% | 8.6% | 9.2% |
| 27 | CET1 (as a percentage of RWA) available after meeting the resolution group's minimum capital and TLAC requirements | 9.0% | 8.8% | 8.8% | 8.6% | 8.5% |
| 28 | Institution-specific buffer (capital conservation buffer plus countercyclical buffer plus higher loss absorbency, expressed as a percentage of RWA) | 3.5% | 3.5% | 3.5% | 3.5% | 3.5% |
| 29 | Of which: capital conservation buffer | 2.5% | 2.5% | 2.5% | 2.5% | 2.5% |
| 30 | Of which: bank specific countercyclical buffer (2) | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| 31 | Of which: D-SIB/G-SIB buffer | 1.0% | 1.0% | 1.0% | 1.0% | 1.0% |

(1) As a D-SIB, CIBC is subject to a target risk-based TLAC Ratio (which comprises a minimum risk-based TLAC ratio of 21.5% plus the then-applicable DSB) and a minimum TLAC Leverage Ratio of 7.25%.
(2) Bank specific countercyclical buffer requirement of 0.03% in Q1/25 (Q4/24: 0.03%) is the amount which is determined based on our weighted average private sector exposures in jurisdictions identified by the BCBS.
n/a Not applicable.

## TLAC3: RESOLUTION ENTITY - CREDITOR RANKING AT LEGAL ENTITY LEVEL (1)(2)

($ millions)

| | Creditor ranking (most junior) | Q1/25 | | | | | (most senior) |
|---|---|---|---|---|---|---|---|
| 1 | Description of creditor ranking | Common shares | Preferred shares and other equity instruments | Subordinated debt | Bail-in debt (3) | Other liabilities (4) | Total |
| 2 | Total capital and liabilities net of CRM | 17,027 | 5,341 | 7,464 | 66,551 | 96,383 |
| 3 | Subset of row 2 that are excluded liabilities | - | - | 58 | 368 | 431 |
| 4 | Total capital and liabilities less excluded liabilities (row 2 minus row 3) | 17,022 | 5,341 | 7,406 | 66,183 | 95,952 |
| 5 | Subset of row 4 that are potentially eligible as TLAC | 17,022 | 5,341 | 5,942 (5) | 48,011 | 76,316 |
| 6 | Subset of row 5 with 1 year $\le$ residual maturity < 2 years | - | - | - | 20,796 | 20,796 |
| 7 | Subset of row 5 with 2 years $\le$ residual maturity < 5 years | - | - | - | 20,115 | 20,115 |
| 8 | Subset of row 5 with 5 years $\le$ residual maturity < 10 years | - | - | 5,942 | 4,960 | 10,902 |
| 9 | Subset of row 5 with residual maturity $\ge$ 10 years, but excluding perpetual securities | - | - | - | 2,140 | 2,140 |
| 10 | Subset of row 5 that is perpetual securities | 17,022 | 5,341 | 2,140 | 22,363 |

($ millions)

| | Creditor ranking (most junior) | Q4/24 | | | | | (most senior) |
|---|---|---|---|---|---|---|---|
| 1 | Description of creditor ranking | Common shares | Preferred shares and other equity instruments | Subordinated debt | Bail-in debt (3) | Other liabilities (4) | Total |
| 2 | Total capital and liabilities net of CRM | 17,011 | 4,946 | 7,516 | 61,496 | 90,969 |
| 3 | Subset of row 2 that are excluded liabilities | - | - | 2 | 64 | 434 | 500 |
| 4 | Total capital and liabilities less excluded liabilities (row 2 minus row 3) | 17,009 | 4,946 | 7,452 | 61,062 | 90,469 |
| 5 | Subset of row 4 that are potentially eligible as TLAC | 17,009 | 4,946 | 5,936 (5) | 43,205 | 71,096 |
| 6 | Subset of row 5 with 1 year $\le$ residual maturity < 2 years | - | - | - | 8,974 | 8,974 |
| 7 | Subset of row 5 with 2 years $\le$ residual maturity < 5 years | - | - | - | 26,217 | 26,217 |
| 8 | Subset of row 5 with 5 years $\le$ residual maturity < 10 years | - | - | 5,936 | 5,883 | 11,819 |
| 9 | Subset of row 5 with residual maturity $\ge$ 10 years, but excluding perpetual securities | - | - | - | 2,131 | 2,131 |
| 10 | Subset of row 5 that is perpetual securities | 17,009 | 4,946 | 21,955 |

($ millions)

| | Creditor ranking (most junior) | Q3/24 | | | | | (most senior) |
|---|---|---|---|---|---|---|---|
| 1 | Description of creditor ranking | Common shares | Preferred shares and other equity instruments | Subordinated debt | Bail-in debt (3) | Other liabilities (4) | Total |
| 2 | Total capital and liabilities net of CRM | 16,919 | 4,949 | 7,516 | 60,642 | 90,026 |
| 3 | Subset of row 2 that are excluded liabilities | - | - | 2 | 37 | 126 | 165 |
| 4 | Total capital and liabilities less excluded liabilities (row 2 minus row 3) | 16,917 | 4,949 | 7,479 | 60,516 | 89,861 |
| 5 | Subset of row 4 that are potentially eligible as TLAC | 16,917 | 4,949 | 5,963 (5) | 41,865 | 69,694 |
| 6 | Subset of row 5 with 1 year $\le$ residual maturity < 2 years | - | - | - | 12,465 | 12,465 |
| 7 | Subset of row 5 with 2 years $\le$ residual maturity < 5 years | - | - | - | 22,652 | 22,652 |
| 8 | Subset of row 5 with 5 years $\le$ residual maturity < 10 years | - | - | 5,963 | 4,700 | 10,663 |
| 9 | Subset of row 5 with residual maturity $\ge$ 10 years, but excluding perpetual securities | - | - | - | 2,048 | 2,048 |
| 10 | Subset of row 5 that is perpetual securities | 16,917 | 4,949 | 21,866 |

(1) Presented for CIBC at the legal entity level and therefore instruments issued by subsidiaries and SPEs are excluded.
(2) Common shares are presented at book value, preferred shares are presented at stated value and subordinated debt and bail-in-debt are presented at face value.
(3) Bail-in debt instruments are those liabilities which are subject to the bank recapitalization (bail-in) conversion regulations issued by the Department of Finance Canada. Senior debt issued on or after September 23, 2018, with an original term to maturity of more than 400 days (including explicit or embedded options) that is unsecured or partially secured is subject to bail-in. Consumer deposits, certain derivatives, covered bonds, and certain structured notes would not be eligible for bail-in. While bail-in debt instruments and other senior unsecured liabilities issued by Canadian D-SIBs rank equally in the event of liquidation, only bail-in debt is subject to conversion under the bail-in regime. Bail-in debt issued by Canadian D-SIBs qualifies as TLAC pursuant to the exemption from the subordination requirement under the antepenultimate paragraph of Section 11 of the FSB TLAC Term Sheet.
(4) Disclosure not currently required by OSFI.
(5) Includes NVCC subordinated debt only.

## TLAC3: RESOLUTION ENTITY - CREDITOR RANKING AT LEGAL ENTITY LEVEL (continued) (1)(2)

($ millions)

| | Creditor ranking (most junior) | Q2/24 | | | | | (most senior) |
|---|---|---|---|---|---|---|---|
| 1 | Description of creditor ranking | Common shares | Preferred shares and other equity instruments | Subordinated debt | Bail-in debt (3) | Other liabilities (4) | Total |
| 2 | Total capital and liabilities net of CRM | 16,813 | 5,098 | 8,014 | 57,787 | 87,712 |
| 3 | Subset of row 2 that are excluded liabilities | - | - | 20 | 130 | 150 |
| 4 | Total capital and liabilities less excluded liabilities (row 2 minus row 3) | 16,813 | 5,098 | 7,994 | 57,657 | 87,562 |
| 5 | Subset of row 4 that are potentially eligible as TLAC | 16,813 | 5,098 | 6,230 (5) | 38,735 | 66,876 |
| 6 | Subset of row 5 with 1 year $\le$ residual maturity < 2 years | - | - | - | 9,827 | 9,827 |
| 7 | Subset of row 5 with 2 years $\le$ residual maturity < 5 years | - | - | - | 22,033 | 22,033 |
| 8 | Subset of row 5 with 5 years $\le$ residual maturity < 10 years | - | - | 6,230 | 4,843 | 11,073 |
| 9 | Subset of row 5 with residual maturity $\ge$ 10 years, but excluding perpetual securities | - | - | - | 2,032 | 2,032 |
| 10 | Subset of row 5 that is perpetual securities | 16,813 | 5,098 | 21,911 |

($ millions)

| | Creditor ranking (most junior) | Q1/24 | | | | | (most senior) |
|---|---|---|---|---|---|---|---|
| 1 | Description of creditor ranking | Common shares | Preferred shares and other equity instruments | Subordinated debt | Bail-in debt (3) | Other liabilities (4) | Total |
| 2 | Total capital and liabilities net of CRM | 16,447 | 4,925 | 8,014 | 57,031 | 86,417 |
| 3 | Subset of row 2 that are excluded liabilities | - | - | 20 | 137 | 157 |
| 4 | Total capital and liabilities less excluded liabilities (row 2 minus row 3) | 16,447 | 4,925 | 7,994 | 56,894 | 86,260 |
| 5 | Subset of row 4 that are potentially eligible as TLAC | 16,447 | 4,925 | 6,230 (5) | 45,420 | 73,022 |
| 6 | Subset of row 5 with 1 year $\le$ residual maturity < 2 years | - | - | - | 17,624 | 17,624 |
| 7 | Subset of row 5 with 2 years $\le$ residual maturity < 5 years | - | - | - | 20,739 | 20,739 |
| 8 | Subset of row 5 with 5 years $\le$ residual maturity < 10 years | - | - | 6,230 | 5,163 | 11,393 |
| 9 | Subset of row 5 with residual maturity $\ge$ 10 years, but excluding perpetual securities | - | - | - | 1,894 | 1,894 |
| 10 | Subset of row 5 that is perpetual securities | 16,447 | 4,925 | 21,372 |

For footnotes, see page 22.

## CCyB1 - GEOGRAPHICAL DISTRIBUTION OF CREDIT EXPOSURES USED IN THE CALCULATION OF THE BANK-SPECIFIC COUNTERCYCLICAL CAPITAL BUFFER REQUIREMENT

($ millions)

| Geographical breakdown | Q1/25 a | Q1/25 b | Q1/25 c | Q1/25 d | Q1/25 e |
|---|---|---|---|---|---|
| | Countercyclical capital buffer rate % | Exposure values | RWA used in the computation of the countercyclical capital buffer | Bank-specific countercyclical capital buffer rate % (1) | Countercyclical capital buffer amount |
| Australia | 1.00 | 5,183 | 1,069 | - | - |
| Belgium | 1.00 | 49 | 16 | - | - |
| Chile | 0.50 | 574 | 252 | - | - |
| Czech Republic | 1.25 | - | - | - | - |
| Denmark | 2.50 | 10 | 6 | - | - |
| France | 1.00 | 1,462 | 211 | - | - |
| Germany | 0.75 | 1,398 | 591 | - | - |
| Hong Kong | 1.00 | 972 | 499 | - | - |
| Luxembourg | 0.50 | 4,017 | 349 | - | - |
| Netherlands | 2.00 | 1,770 | 675 | - | - |
| Norway | 2.50 | 220 | 51 | - | - |
| South Korea | 1.00 | 2 | 1 | - | - |
| Sweden | 2.00 | 801 | 247 | - | - |
| United Kingdom | 2.00 | 19,968 | 2,531 | - | - |
| Sum (2) | | 36,427 | 6,498 | 0.0% | 131 (4) |
| Total (3) | | 1,125,994 | 249,911 | | |

($ millions)

| Geographical breakdown | Q4/24 a | Q4/24 b | Q4/24 c | Q4/24 d | Q4/24 e |
|---|---|---|---|---|---|
| | Countercyclical capital buffer rate % | Exposure values | RWA used in the computation of the countercyclical capital buffer | Bank-specific countercyclical capital buffer rate % (1) | Countercyclical capital buffer amount |
| Australia | 1.00 | 5,636 | 1,160 | - | - |
| Belgium | 1.00 | 58 | 22 | - | - |
| France | 1.00 | 743 | 64 | - | - |
| Germany | 0.75 | 1,090 | 507 | - | - |
| Hong Kong | 1.00 | 981 | 497 | - | - |
| Luxembourg | 0.50 | 2,870 | 319 | - | - |
| Netherlands | 2.00 | 1,731 | 663 | - | - |
| Norway | 2.50 | 243 | 29 | - | - |
| South Korea | 1.00 | 5 | 2 | - | - |
| Sweden | 2.00 | 731 | 230 | - | - |
| United Kingdom | 2.00 | 20,720 | 2,368 | - | - |
| Sum (2) | | 34,808 | 5,859 | 0.0% | 121 (4) |
| Total (3) | | 1,042,843 | 242,881 | | |

(1) Bank specific countercyclical buffer requirement of 0.03% in Q1/25 (Q4/24: 0.03%) is the amount which is determined based on our weighted average private sector exposures in jurisdictions identified by the BCBS.
(2) Sum of private sector credit exposures or RWA for private sector credit exposures, respectively, in jurisdictions with a non-zero countercyclical capital buffer rate.
(3) Total of private sector credit exposures or RWA for private sector credit exposures, respectively, across all jurisdictions to which the bank is exposed, including jurisdictions with no countercyclical capital buffer rate or with a countercyclical capital buffer rate set at zero, and value of the bank-specific countercyclical capital buffer rate and resulting countercyclical capital buffer amount.
(4) Computed using the total RWA of \$341,930 million (Q4/24: \$333,502 million), multiplied by the bank-specific countercyclical capital buffer rate.

## CCyB1 - GEOGRAPHICAL DISTRIBUTION OF CREDIT EXPOSURES USED IN THE CALCULATION OF THE BANK-SPECIFIC COUNTERCYCLICAL CAPITAL BUFFER REQUIREMENT (continued)

($ millions)

| Geographical breakdown | Q3/24 a | Q3/24 b | Q3/24 c | Q3/24 d | Q3/24 e |
|---|---|---|---|---|---|
| | Countercyclical capital buffer rate % | Exposure values | RWA used in the computation of the countercyclical capital buffer | Bank-specific countercyclical capital buffer rate % (1) | Countercyclical capital buffer amount |
| Australia | 1.00 | 5,803 | 1,112 | - | - |
| Belgium | 0.50 | 97 | 31 | - | - |
| France | 1.00 | 1,294 | 77 | - | - |
| Germany | 0.75 | 1,548 | 638 | - | - |
| Hong Kong | 1.00 | 966 | 496 | - | - |
| Luxembourg | 0.50 | 3,042 | 256 | - | - |
| Netherlands | 2.00 | 1,472 | 571 | - | - |
| Norway | 2.50 | 246 | 32 | - | - |
| South Korea | 1.00 | 4 | 4 | - | - |
| Sweden | 2.00 | 955 | 275 | - | - |
| United Kingdom | 2.00 | 20,033 | 2,196 | - | - |
| Sum (2) | | 35,460 | 5,688 | 0.0% | 115 |
| Total (3) | | 1,050,349 | 242,830 | | |

($ millions)

| Geographical breakdown | Q2/24 a | Q2/24 b | Q2/24 c | Q2/24 d | Q2/24 e |
|---|---|---|---|---|---|
| | Countercyclical capital buffer rate % | Exposure values | RWA used in the computation of the countercyclical capital buffer | Bank-specific countercyclical capital buffer rate % (1) | Countercyclical capital buffer amount |
| Australia | 1.00 | 7,294 | 1,135 | - | - |
| France | 0.50 | 539 | 76 | - | - |
| Germany | 0.75 | 1,354 | 552 | - | - |
| Hong Kong | 1.00 | 1,073 | 527 | - | - |
| Luxembourg | 0.50 | 1,648 | 272 | - | - |
| Netherlands | 1.00 | 1,589 | 667 | - | - |
| Norway | 2.50 | 388 | 54 | - | - |
| Sweden | 1.00 | 951 | 244 | - | - |
| United Kingdom | 1.00 | 19,199 | 2,247 | - | - |
| Sum (2) | | 34,035 | 5,774 | 0.0% | 74 |
| Total (3) | | 1,039,588 | 243,089 | | |

($ millions)

| Geographical breakdown | Q1/24 a | Q1/24 b | Q1/24 c | Q1/24 d | Q1/24 e |
|---|---|---|---|---|---|
| | Countercyclical capital buffer rate % | Exposure values | RWA used in the computation of the countercyclical capital buffer | Bank-specific countercyclical capital buffer rate % (1) | Countercyclical capital buffer amount |
| Australia | 1.00 | 7,257 | 1,215 | - | - |
| France | 0.50 | 2,710 | 86 | - | - |
| Germany | 0.75 | 1,413 | 566 | - | - |
| Hong Kong | 1.00 | 1,068 | 528 | - | - |
| Luxembourg | 0.50 | 2,786 | 372 | - | - |
| Netherlands | 1.00 | 1,641 | 700 | - | - |
| Norway | 2.50 | 385 | 56 | - | - |
| Sweden | 1.00 | 1,041 | 255 | - | - |
| United Kingdom | 1.00 | 14,727 | 2,107 | - | - |
| Sum (2) | | 33,028 | 5,885 | 0.0% | 68 |
| Total (3) | | 990,146 | 234,278 | | |

For footnotes, see page 24.

## LR1: SUMMARY COMPARISON OF ACCOUNTING ASSETS VS. LEVERAGE RATIO EXPOSURE MEASURE

($ millions)

| Row | Q1/25 | Q4/24 | Q3/24 | Q2/24 | Q1/24 |
|---|---|---|---|---|---|
| 1 | Total consolidated assets as per published financial statements | 1,082,464 | 1,041,985 | 1,021,407 | 1,001,758 | 971,667 |
| 2 | Adjustment for investments in banking, financial, insurance or commercial entities that are consolidated for accounting purposes but outside the scope of regulatory consolidation | (18) | (19) | (18) | (15) | (17) |
| 3 | Adjustment for securitized exposures that meet the operational requirements for the recognition of risk transference | (2,675) | (3,389) | (3,852) | (2,938) | (3,244) |
| 4 | Adjustment for fiduciary assets recognized on the balance sheet pursuant to the operative accounting framework but excluded from the leverage ratio exposure measure | 2,623 | 1,115 | 4,074 | 3,062 | 7,437 |
| 5 | Adjustment for derivative financial instruments | 5,194 | 1,778 | 3,513 | 2,589 | 403 |
| 6 | Adjustment for SFTs (i.e., repos and similar secured lending) | 137,228 | 130,274 | 124,633 | 122,937 | 118,897 |
| 7 | Adjustment for off-balance sheet items (i.e., credit equivalent amounts of off-balance sheet exposures) | (19,296) | (16,312) | (15,774) | (14,982) | (14,237) |
| 8 | Other adjustments | 1,205,520 | 1,155,432 | 1,133,983 | 1,112,411 | 1,080,906 |
| 9 | Leverage ratio exposure measure | | | | | |

## LR2: LEVERAGE RATIO COMMON DISCLOSURE TEMPLATE

| Row | On-balance sheet exposures | Q1/25 | Q4/24 | Q3/24 | Q2/24 | Q1/24 |
|---|---|---|---|---|---|---|
| 1 | On-balance sheet items (excluding derivatives, SFTs and grandfathered securitization exposures, but including collateral) | 936,448 | 901,391 | 891,410 | 867,599 | 851,313 |
| 2 | Gross up for derivatives collateral provided where deducted from the balance sheet assets pursuant to the operative accounting framework (IFRS) | (9,383) | (6,919) | (6,890) | (7,278) | (6,155) |
| 3 | (Deductions of receivables assets for cash variation margin provided in derivative transactions) | (9,914) | (9,391) | (8,884) | (7,705) | (8,080) |
| 4 | (Asset amounts deducted in determining T1 capital) | 917,151 | 885,081 | 875,636 | 852,616 | 837,078 |
| 5 | Total on-balance sheet exposures (excluding derivatives and SFTs) (sum of lines 1 to 4) | | | | | |
| **Derivative exposures** | | | | | | |
| 6 | Replacement cost associated with all derivative transactions | 11,652 | 10,599 | 8,430 | 8,762 | 7,318 |
| 7 | Add-on amounts for potential future exposure associated with all derivative transactions | 29,543 | 26,950 | 25,955 | 25,710 | 24,753 |
| 8 | Adjusted effective notional amount of written credit derivatives | 3,593 | 3,399 | 2,909 | 3,739 | 4,329 |
| 9 | (Exempted central counterparty (CCP)-leg of client cleared trade exposures) | (3,593) | (3,399) | (2,909) | (3,739) | (4,329) |
| 10 | (Adjusted effective notional offsets and add-on deductions for written credit derivatives) | 41,195 | 37,549 | 34,385 | 34,472 | 32,071 |
| 11 | Total derivatives exposures (sum of lines 6 to 10) | | | | | |
| **SFT exposures** | | | | | | |
| 12 | Gross SFT assets recognized for accounting purposes (with no recognition of netting), after adjusting for sale accounting transactions | 104,752 | 100,750 | 95,816 | 99,797 | 92,458 |
| 13 | (Netted amounts of cash payables and cash receivables of gross SFT assets) | (6,076) | (6,196) | (4,542) | (3,780) | (4,920) |
| 14 | Counterparty credit risk exposure for SFTs | 11,270 | 7,974 | 8,055 | 6,369 | 5,322 |
| 15 | Agent transaction exposures | 109,946 | 102,528 | 99,329 | 102,386 | 92,860 |
| 16 | Total SFT exposures (sum of lines 12 to 15) | | | | | |
| **Other off-balance sheet exposures** | | | | | | |
| 17 | Off-balance sheet exposure at gross notional amount | 445,447 | 430,273 | 415,295 | 410,149 | 401,046 |
| 18 | (Adjustments for conversion to credit equivalent amounts) | (308,219) | (299,999) | (290,662) | (287,212) | (282,149) |
| 19 | Off-balance sheet items (sum of lines 17 and 18) | 137,228 | 130,274 | 124,633 | 122,937 | 118,897 |
| **Capital and Total Exposures** | | | | | | |
| 20 | T1 capital | 51,574 | 49,481 | 48,751 | 47,845 | 46,103 |
| 21 | Total Exposures (sum of lines 5, 11, 16 and 19) | 1,205,520 | 1,155,432 | 1,133,983 | 1,112,411 | 1,080,906 |
| 22 | Leverage Ratio | 4.3% | 4.3% | 4.3% | 4.3% | 4.3% |

## CR1: CREDIT QUALITY OF ASSETS

($ millions)

| | | Q1/25 a | Q1/25 b | Q1/25 c | Q1/25 d | Q1/25 e | Q1/25 f | Q1/25 g |
|---|---|---|---|---|---|---|---|---|
| | **Gross carrying values of** | **Defaulted exposures** | **Non-defaulted exposures** | **Allowances/ impairments** | **Of which ECL accounting provisions for credit losses on SA exposures (1)** | | **Of which ECL accounting provisions for credit losses on IRB exposures** | **Net value (a+b-c)** |
| | | | | | Allocated in regulatory category of specific | Allocated in regulatory category of general | | |
| 1 | Loans | 3,262 | 568,961 | 4,104 | 193 | 249 | 3,662 | 568,119 |
| 2 | Debt securities | 468 | 200,000 | 37 | 12 | 25 | - | 200,431 |
| 2a | Other investment (2) | - | 3 | - | - | - | - | 3 |
| 3 | Off-balance sheet exposures (3) | 250 | 444,738 | 272 | - | - | 262 | 444,716 |
| 4 | Total | 3,980 | 1,213,702 | 4,413 | 205 | 284 | 3,924 | 1,213,269 |

($ millions)

| | | Q4/24 a | Q4/24 b | Q4/24 c | Q4/24 d | Q4/24 e | Q4/24 f | Q4/24 g |
|---|---|---|---|---|---|---|---|
| | **Gross carrying values of** | **Defaulted exposures** | **Non-defaulted exposures** | **Allowances/ impairments** | **Of which ECL accounting provisions for credit losses on SA exposures (1)** | | **Of which ECL accounting provisions for credit losses on IRB exposures** | **Net value (a+b-c)** |
| | | | | | Allocated in regulatory category of specific | Allocated in regulatory category of general | | |
| 1 | Loans | 2,914 | 559,295 | 3,917 | 176 | 240 | 3,501 | 558,292 |
| 2 | Debt securities | 457 | 192,464 | 36 | 12 | 24 | - | 192,885 |
| 2a | Other investment (2) | - | 3 | - | - | - | - | 3 |
| 3 | Off-balance sheet exposures (3) | 166 | 429,814 | 197 | 5 | 188 | 192 | 429,783 |
| 4 | Total | 3,537 | 1,181,576 | 4,150 | 188 | 269 | 3,693 | 1,180,963 |

($ millions)

| | | Q3/24 a | Q3/24 b | Q3/24 c | Q3/24 d | Q3/24 e | Q3/24 f | Q3/24 g |
|---|---|---|---|---|---|---|---|
| | **Gross carrying values of** | **Defaulted exposures** | **Non-defaulted exposures** | **Allowances/ impairments** | **Of which ECL accounting provisions for credit losses on SA exposures (1)** | | **Of which ECL accounting provisions for credit losses on IRB exposures** | **Net value (a+b-c)** |
| | | | | | Allocated in regulatory category of specific | Allocated in regulatory category of general | | |
| 1 | Loans | 2,757 | 551,312 | 3,920 | 187 | 251 | - | 3,482 | 550,149 |
| 2 | Debt securities | 461 | 189,971 | 37 | 12 | 24 | - | 190,395 |
| 2a | Other investment (2) | - | 4 | - | - | - | - | 4 |
| 3 | Off-balance sheet exposures (3) | 339 | 414,747 | 198 | 5 | 193 | - | 414,888 |
| 4 | Total | 3,557 | 1,156,034 | 4,155 | 199 | 280 | 3,676 | 1,155,436 |

(1) For SA exposures, stage 3 allowances are reflected in the category of specific, and stage 1 and 2 allowances are reflected in the category of general.
(2) Other investments include equity investments subject to the credit risk framework.
(3) Includes \$192.9 billion (Q4/24: \$189.6 billion) of personal, home equity and credit card lines, which are unconditionally cancellable at our discretion.

## CR1: CREDIT QUALITY OF ASSETS (continued)

($ millions)

| | | Q2/24 a | Q2/24 b | Q2/24 c | Q2/24 d | Q2/24 e | Q2/24 f | Q2/24 g |
|---|---|---|---|---|---|---|---|---|
| | **Gross carrying values of** | **Defaulted exposures** | **Non-defaulted exposures** | **Allowances/ impairments** | **Of which ECL accounting provisions for credit losses on SA exposures (1)** | | **Of which ECL accounting provisions for credit losses on IRB exposures** | **Net value (a+b-c)** |
| | | | | | Allocated in regulatory category of specific | Allocated in regulatory category of general | | |
| 1 | Loans | 2,849 | 544,946 | 3,898 | 183 | 244 | 3,471 | 543,897 |
| 2 | Debt securities | 465 | 176,555 | 38 | 13 | 24 | 1 | 176,982 |
| 2a | Other investment (2) | - | 4 | - | - | - | - | 4 |
| 3 | Off-balance sheet exposures (3) | 266 | 409,020 | 188 | 5 | 183 | - | 409,098 |
| 4 | Total | 3,580 | 1,130,525 | 4,124 | 196 | 273 | 3,655 | 1,129,981 |

($ millions)

| | | Q1/24 a | Q1/24 b | Q1/24 c | Q1/24 d | Q1/24 e | Q1/24 f | Q1/24 g |
|---|---|---|---|---|---|---|---|
| | **Gross carrying values of** | **Defaulted exposures** | **Non-defaulted exposures** | **Allowances/ impairments** | **Of which ECL accounting provisions for credit losses on SA exposures (1)** | | **Of which ECL accounting provisions for credit losses on IRB exposures** | **Net value (a+b-c)** |
| | | | | | Allocated in regulatory category of specific | Allocated in regulatory category of general | | |
| 1 | Loans | 2,997 | 540,318 | 4,020 | 184 | 243 | 3,593 | 539,295 |
| 2 | Debt securities | 461 | 173,290 | 40 | 13 | 26 | 1 | 173,711 |
| 2a | Other investment (2) | - | 3 | - | - | - | - | 3 |
| 3 | Off-balance sheet exposures (3) | 226 | 400,496 | 162 | 5 | 157 | - | 400,560 |
| 4 | Total | 3,684 | 1,114,107 | 4,222 | 197 | 274 | 3,751 | 1,113,569 |

For footnotes, see page 27.

## CR2: CHANGES IN STOCK OF DEFAULTED LOANS AND DEBT SECURITIES (1)

($ millions)

| | | Q1/25 a | Q4/24 b | Q3/24 c | Q2/24 d | Q1/24 e |
|---|---|---|---|---|---|---|
| 1 | Defaulted loans and debt securities at end of the previous reporting period | 3,537 | 3,557 | 3,580 | 3,684 | 3,671 |
| 2 | Loans and debt securities that have defaulted since the last reporting period | 1,408 | 1,305 | 1,157 | 1,072 | 1,089 |
| | Amounts repaid (2) | (540) | (500) | (619) | (417) | (350) |
| 3 | Returned to non-defaulted status | (160) | (184) | (141) | (146) | (166) |
| 4 | Amounts written off | (421) | (473) | (494) | (698) | (511) |
| 5 | Other changes (3) | 156 | (168) | 74 | 85 | (49) |
| 6 | Defaulted loans and debt securities at end of the reporting period | 3,980 | 3,537 | 3,557 | 3,580 | 3,684 |

(1) Includes off-balance sheet exposures.
(2) Includes proceeds from the disposal of loans.
(3) Includes changes due to foreign exchange movements.

## CR3: CRM TECHNIQUES - OVERVIEW (1)

($ millions)

| | | Q1/25 a | Q1/25 b1 | Q1/25 b | Q1/25 d | Q1/25 f |
|---|---|---|---|---|---|---|
| | | Exposure unsecured: carrying amount (2) | Exposure secured (3) | Exposure secured by collateral (4) | Exposures secured by financial guarantees | Exposures secured by credit derivatives (5) |
| 1 | Loans | 68,933 | 499,186 | 495,379 | 3,807 | - |
| 2 | Debt securities | 172,686 | 27,745 | 4,557 | 23,188 | - |
| 3 | Total (3) | 241,619 | 526,931 | 499,936 | 26,995 | - |
| 4 | Of which defaulted (6) | 595 | 1,752 | 1,752 | - | - |

($ millions)

| | | Q4/24 a | Q4/24 b1 | Q4/24 b | Q4/24 d | Q4/24 f |
|---|---|---|---|---|---|---|
| | | Exposure unsecured: carrying amount (2) | Exposure secured (3) | Exposure secured by collateral (4) | Exposures secured by financial guarantees | Exposures secured by credit derivatives (5) |
| 1 | Loans | 67,889 | 490,403 | 486,885 | 3,518 | - |
| 2 | Debt securities | 168,295 | 24,590 | 3,624 | 20,966 | - |
| 3 | Total (3) | 236,184 | 514,993 | 490,509 | 24,484 | - |
| 4 | Of which defaulted (6) | 533 | 2,010 | 2,010 | - | - |

($ millions)

| | | Q3/24 a | Q3/24 b1 | Q3/24 b | Q3/24 d | Q3/24 f |
|---|---|---|---|---|---|---|
| | | Exposure unsecured: carrying amount (2) | Exposure secured (3) | Exposure secured by collateral (4) | Exposures secured by financial guarantees | Exposures secured by credit derivatives (5) |
| 1 | Loans | 65,913 | 484,236 | 481,238 | 2,998 | - |
| 2 | Debt securities | 166,482 | 23,913 | 3,021 | 20,892 | - |
| 3 | Total (3) | 232,395 | 508,149 | 484,259 | 23,890 | - |
| 4 | Of which defaulted (6) | 554 | 1,823 | 1,823 | - | - |

($ millions)

| | | Q2/24 a | Q2/24 b1 | Q2/24 b | Q2/24 d | Q2/24 f |
|---|---|---|---|---|---|---|
| | | Exposure unsecured: carrying amount (2) | Exposure secured (3) | Exposure secured by collateral (4) | Exposures secured by financial guarantees | Exposures secured by credit derivatives (5) |
| 1 | Loans | 69,141 | 474,756 | 472,384 | 2,372 | - |
| 2 | Debt securities | 152,824 | 24,158 | 3,273 | 20,885 | - |
| 3 | Total (3) | 221,965 | 498,914 | 475,657 | 23,257 | - |
| 4 | Of which defaulted (6) | 521 | 1,895 | 1,895 | - | - |

($ millions)

| | | Q1/24 a | Q1/24 b1 | Q1/24 b | Q1/24 d | Q1/24 f |
|---|---|---|---|---|---|---|
| | | Exposure unsecured: carrying amount (2) | Exposure secured (3) | Exposure secured by collateral (4) | Exposures secured by financial guarantees | Exposures secured by credit derivatives (5) |
| 1 | Loans | 66,178 | 473,117 | 470,874 | 2,243 | - |
| 2 | Debt securities | 151,377 | 22,334 | 3,239 | 19,095 | - |
| 3 | Total (3) | 217,555 | 495,451 | 474,113 | 21,338 | - |
| 4 | Of which defaulted (6) | 585 | 1,787 | 1,781 | 6 | - |

(1) Excludes off-balance sheet exposures.
(2) Includes fully unsecured exposures and the unsecured portion of partially-secured exposures.
(3) Amounts reflect the entire carrying value of exposures which are secured by either collateral or financial guarantees.
(4) All residential mortgages are included in exposure secured by collateral.
(5) Excludes derivatives which do not qualify in reducing exposures considered for regulatory capital purposes. For exposures secured by more than one form of security, exposures are first reduced by the amount secured by collateral, and then financial guarantees and credit derivatives, as applicable.
(6) Amounts are net of allowance for credit losses.

## CR4: SA - CREDIT RISK EXPOSURE AND CRM EFFECTS

($ millions)

| Asset classes | Q1/25 a | Q1/25 b | Q1/25 c | Q1/25 d | Q1/25 e | Q1/25 f |
|---|---|---|---|---|---|---|
| | On-balance sheet amount | Off-balance sheet amount | On-balance sheet amount | Off-balance sheet amount | RWA | RWA density % |
| **Exposures before CCF (1) and CRM** | **Exposures post-CCF and CRM** | |
| 1 | Sovereigns and their central banks | 6,202 | 170 | 6,522 | 239 | 890 | 4 |
| 2 | PSES | 1,001 | 199 | 1,066 | 86 | 77 | 7 |
| 3 | MDBs | 722 | - | 722 | - | 144 | 20 |
| 4 | Banks | 1,250 | - | 1,250 | - | 333 | 27 |
| | Of which: securities firms and other financial institutions treated as banks | - | - | - | - | - | - |
| 5 | Covered bonds | - | - | - | - | - | - |
| 6 | Corporates | 6,877 | 3,399 | 6,696 | 1,331 | 7,231 | 90 |
| | Of which: securities firms and other financial institutions treated as corporates | 598 | 264 | 592 | 91 | 695 | 102 |
| 7 | Of which: specialized lending | 1,364 | 117 | 1,364 | 47 | 1,541 | 109 |
| 8 | Subordinated debt, equity and other capital | 3,910 | 16,668 | 3,908 | 4,255 | 3,643 | 45 |
| 9 | Retail | 3,722 | 58 | 3,542 | 24 | 1,632 | 46 |
| | Of which: general residential real estate (general RRE) | 3,025 | - | 2,885 | - | 996 | 35 |
| | Of which: income-producing residential real estate (IPRRE) | 186 | - | 169 | - | 83 | 49 |
| | Of which: other residential real estate (other RRE) | - | - | - | - | - | - |
| | Of which: general commercial real estate (general CRE) | 255 | 1 | 233 | 1 | 233 | 100 |
| | Of which: income-producing commercial real estate (IPCRE) | 211 | - | 210 | - | 218 | 104 |
| | Of which: land acquisition, development and construction | 45 | 57 | 45 | 23 | 102 | 150 |
| 10 | Reverse mortgages | - | - | - | - | - | - |
| 11 | MBS | 415 | 2 | 192 | 2 | 220 | 113 |
| 12 | Defaulted exposures (2) | 20,437 | - | 20,437 | - | 8,117 | 40 |
| 13 | Other assets (3) | 45,900 | 20,613 | 45,699 | 5,984 | 24,047 | 47 |
| 14 | Total | | | | | | |

($ millions)

| Asset classes | Q4/24 a | Q4/24 b | Q4/24 c | Q4/24 d | Q4/24 e | Q4/24 f |
|---|---|---|---|---|---|---|
| | On-balance sheet amount | Off-balance sheet amount | On-balance sheet amount | Off-balance sheet amount | RWA | RWA density % |
| **Exposures before CCF (1) and CRM** | **Exposures post-CCF and CRM** | |
| 1 | Sovereigns and their central banks | 5,760 | 161 | 6,074 | 254 | 289 | 5 |
| 2 | PSES | 976 | 181 | 1,032 | 81 | 865 | 78 |
| 3 | MDBs | 696 | - | 696 | - | 139 | 20 |
| 4 | Banks | 1,298 | - | 1,298 | - | 328 | 25 |
| | Of which: securities firms and other financial institutions treated as banks | - | - | - | - | - | - |
| 5 | Covered bonds | - | - | - | - | - | - |
| 6 | Corporates | 6,432 | 3,448 | 6,182 | 1,303 | 6,699 | 89 |
| | Of which: securities firms and other financial institutions treated as corporates | 543 | 264 | 529 | 84 | 626 | 102 |
| 7 | Of which: specialized lending | 1,000 | 113 | 1,000 | 45 | 1,427 | 137 |
| 8 | Subordinated debt, equity and other capital | 3,811 | 16,030 | 3,808 | 4,094 | 3,404 | 43 |
| 9 | Retail | 3,608 | 80 | 3,420 | 31 | 1,605 | 47 |
| | Of which: general RRE | 2,920 | 4 | 2,777 | 1 | 970 | 35 |
| | Of which: IPRRE | 185 | - | 165 | - | 82 | 50 |
| | Of which: other RRE | - | - | - | - | - | - |
| | Of which: general CRE | 247 | 5 | 222 | 1 | 221 | 99 |
| | Of which: IPCRE | 211 | 2 | 211 | 1 | 223 | 105 |
| | Of which: land acquisition, development and construction | 45 | 69 | 45 | 28 | 109 | 149 |
| 10 | Reverse mortgages | - | - | - | - | - | - |
| 11 | MBS | 2 | 2 | 2 | 2 | 2 | 129 |
| 12 | Defaulted exposures (2) | 486 | 2 | 284 | 2 | 368 | 129 |
| 13 | Other assets (3) | 17,869 | - | 17,869 | - | 8,698 | 49 |
| 14 | Total | 41,936 | 20,015 | 41,663 | 5,810 | 23,822 | 50 |

($ millions)

| Asset classes | Q3/24 a | Q3/24 b | Q3/24 c | Q3/24 d | Q3/24 e | Q3/24 f |
|---|---|---|---|---|---|---|
| | On-balance sheet amount | Off-balance sheet amount | On-balance sheet amount | Off-balance sheet amount | RWA | RWA density % |
| **Exposures before CCF (1) and CRM** | **Exposures post-CCF and CRM** | |
| 1 | Sovereigns and their central banks | 5,869 | 37 | 6,282 | 198 | 914 | 76 |
| 2 | PSES | 1,063 | 179 | 1,114 | 82 | 890 | 91 |
| 3 | MDBs | 676 | - | 676 | - | 135 | 20 |
| 4 | Banks | 970 | - | 970 | - | 270 | 28 |
| | Of which: securities firms and other financial institutions treated as banks | - | - | - | - | - | - |
| 5 | Covered bonds | - | - | - | - | - | - |
| 6 | Corporates | 6,267 | 3,276 | 6,012 | 1,218 | 6,483 | 90 |
| | Of which: securities firms and other financial institutions treated as corporates | 553 | 253 | 548 | 84 | 647 | 102 |
| 7 | Of which: specialized lending | 946 | 84 | 946 | 34 | 1,322 | 135 |
| 8 | Subordinated debt, equity and other capital | 3,509 | 15,779 | 3,510 | 4,034 | 3,208 | 43 |
| 9 | Retail | 3,483 | 94 | 3,289 | 36 | 1,556 | 47 |
| | Of which: general RRE | 2,828 | 5 | 2,680 | 2 | 947 | 35 |
| | Of which: IPRRE | 186 | - | 166 | - | 82 | 49 |
| | Of which: other RRE | - | - | - | - | - | - |
| | Of which: general CRE | 223 | 8 | 198 | 2 | 199 | 100 |
| | Of which: IPCRE | 202 | 3 | 201 | 1 | 215 | 106 |
| | Of which: land acquisition, development and construction | 44 | 78 | 44 | 31 | 113 | 151 |
| 10 | Reverse mortgages | - | - | - | - | - | - |
| 11 | MBS | 460 | 2 | 251 | 2 | 317 | 125 |
| 12 | Defaulted exposures (2) | 17,417 | - | 17,417 | - | 8,225 | 47 |
| 13 | Other assets (3) | 40,660 | 19,451 | 40,467 | 5,604 | 22,725 | 49 |
| 14 | Total | | | | | | |

($ millions)

| Asset classes | Q2/24 a | Q2/24 b | Q2/24 c | Q2/24 d | Q2/24 e | Q2/24 f |
|---|---|---|---|---|---|---|
| | On-balance sheet amount | Off-balance sheet amount | On-balance sheet amount | Off-balance sheet amount | RWA | RWA density % |
| **Exposures before CCF (1) and CRM** | **Exposures post-CCF and CRM** | |
| 1 | Sovereigns and their central banks | 6,191 | 36 | 6,622 | 177 | 287 | 4 |
| 2 | PSES | 1,024 | 164 | 1,084 | 72 | 885 | 77 |
| 3 | MDBs | 705 | - | 705 | - | 141 | 20 |
| 4 | Banks | 833 | - | 833 | - | 242 | 29 |
| | Of which: securities firms and other financial institutions treated as banks | - | - | - | - | - | - |
| 5 | Covered bonds | - | - | - | - | - | - |
| 6 | Corporates | 6,140 | 3,358 | 5,872 | 1,258 | 6,393 | 90 |
| | Of which: securities firms and other financial institutions treated as corporates | 575 | 269 | 572 | 89 | 677 | 102 |
| 7 | Of which: specialized lending | 922 | 80 | 922 | 32 | 1,208 | 127 |
| 8 | Subordinated debt, equity and other capital | 4,936 | 15,664 | 4,936 | 4,007 | 3,901 | 44 |
| 9 | Retail | 3,472 | 80 | 3,269 | 31 | 1,522 | 46 |
| | Of which: general RRE | 2,837 | 5 | 2,679 | 2 | 944 | 35 |
| | Of which: IPRRE | 189 | - | 168 | - | 81 | 48 |
| | Of which: other RRE | - | - | - | - | - | - |
| | Of which: general CRE | 219 | 5 | 196 | 1 | 197 | 100 |
| | Of which: IPCRE | 187 | 3 | 186 | 1 | 200 | 107 |
| | Of which: land acquisition, development and construction | 40 | 67 | 40 | 27 | 100 | 149 |
| 10 | Reverse mortgages | - | - | - | - | - | - |
| 11 | MBS | 417 | 1 | 211 | 1 | 253 | 119 |
| 12 | Defaulted exposures (2) | 17,592 | - | 17,592 | - | 7,953 | 45 |
| 13 | Other assets (3) | 42,232 | 19,383 | 42,046 | 5,578 | 22,785 | 48 |
| 14 | Total | | | | | | |

For footnotes, see page 31.

## CR5: SA - EXPOSURES BY ASSET CLASSES AND RISK-WEIGHTS

($ millions)

| Asset classes | Q1/25 Risk weight | | | | | | | | | | | | | | | | | | | | | | | | | | Total credit exposure amount (post-CCF and post-CRM) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | 0% | 15% | 20% | 25% | 30% | 35% | 40% | 45% | 50% | 55% | 60% | 65% | 70% | 75% | 80% | 85% | 90% | 100% | 105% | 110% | 130% | 150% | 250% | 400% | 1250% | Others |
| 1 | Sovereigns and their central banks | 6,421 | 13 | 69 | 258 | - | - | - | - | - | - | - | - | - | - | - | - | - | 617 | 73 | - | - | - | - | - | - | 6,761 |
| 2 | PSES | 59 | 124 | 279 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 611 | - | - | - | - | - | - | 1,152 |
| 3 | MDBs | 722 | - | - | 32 | - | - | - | - | - | - | - | - | - | - | - | - | - | 17 | - | - | - | - | - | - | 722 |
| 4 | Banks | 1,156 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 45 | - | - | - | - | - | - | 1,250 |
| | Of which: securities firms and other financial institutions | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 5 | Covered bonds | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5,389 | - | - | - | - | 2,614 | - | - | - | - | 8,027 |
| 6 | Corporates | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 683 |
| | Of which: specialized lending | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 659 | - | - | - | - | 24 | - | - | - | - | - |
| 7 | Subordinated debt, equity and other capital | 279 | 7 | 326 | 441 | 398 | 369 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1,411 |
| 8 | Retail | 803 | 326 | 441 | 398 | 369 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8,163 |
| 9 | Real estate | 803 | 326 | 395 | 380 | 369 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3,566 |
| | Of which: general RRE | 46 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2,885 |
| | Of which: IPRRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 169 |
| | Of which: other RRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| | Of which: general CRE | 228 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 234 |
| | Of which: IPCRE | 46 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 210 |
| | Of which: land acquisition, development and construction | 6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 68 |
| 10 | Reverse mortgages | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 11 | MBS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 12 | Defaulted exposures | 12,319 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 19,078 |
| 13 | Other assets (1) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 14 | Total | 19,078 | 4,132 | 2,825 | 326 | 441 | 398 | 369 | 27 | 771 | 26 | 255 | 4,056 | 5,389 | 46 | 12,843 | 5 | 155 | 264 | 277 | 20,437 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | 51,683 |

Exposure amounts and CCFs applied to off-balance sheet exposures, categorized based on risk bucket of converted exposures.

($ millions)

| Risk weight | Q1/25 a | Q1/25 b | Q1/25 d | Q1/25 e | Q1/25 f |
|---|---|---|---|---|---|
| | On-balance sheet exposure | Off-balance sheet exposure (pre-CCF) | Weighted Average CCF% | Exposure (post-CCF and post-CRM) | RWA | Exposure density % |
| 1 | Less than 40% | 23,494 | 12,481 | 26% | 27,200 |
| 2 | 40-70% | 1,492 | 80 | 40% | 1,448 |
| 3 | 75-80% | 2,938 | 4,371 | 26% | 4,056 |
| 4 | 85% | 4,435 | 2,252 | 44% | 5,389 |
| 5 | 90-100% | 12,870 | 1,323 | 46% | 12,889 |
| 6 | 105-130% | 163 | 0 | 0% | 160 |
| 7 | 150% | 258 | 59 | 42% | 264 |
| 8 | 250% | 258 | 47 | 40% | 277 |
| 9 | 400% | - | - | - | - |
| 10 | 1250% | 45,900 | 20,613 | 29% | 51,683 |
| 11 | Total exposures | | | | | |

(1) Excludes exposures that are deducted from regulatory capital.
(2) Weighting is based on off-balance sheet exposure (pre-CCF).

## CR5: SA - EXPOSURES BY ASSET CLASSES AND RISK-WEIGHTS (continued)

($ millions)

| Asset classes | Q4/24 Risk weight | | | | | | | | | | | | | | | | | | | | | | | | | | Total credit exposure amount (post-CCF and post-CRM) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | 0% | 15% | 20% | 25% | 30% | 35% | 40% | 45% | 50% | 55% | 60% | 65% | 70% | 75% | 80% | 85% | 90% | 100% | 105% | 110% | 130% | 150% | 250% | 400% | 1250% | Others |
| 1 | Sovereigns and their central banks | 5,993 | 12 | 72 | 251 | - | - | - | - | - | - | - | - | - | - | - | - | - | 611 | 68 | - | - | - | - | - | - | 6,328 |
| 2 | PSES | 60 | 113 | 261 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 611 | - | - | - | - | - | - | 1,113 |
| 3 | MDBs | 696 | - | - | 21 | - | - | - | - | - | - | - | - | - | - | - | - | - | 12 | - | - | - | - | - | - | 696 |
| 4 | Banks | 1,225 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 40 | - | - | - | - | - | - | 1,298 |
| | Of which: securities firms and other financial institutions treated as banks | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 5 | Covered bonds | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5,337 | - | - | - | - | 2,123 | - | - | - | - | 7,485 |
| 6 | Corporates | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 613 |
| | Of which: specialized lending | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 780 | - | - | - | - | 258 | - | - | - | - | - |
| 7 | Subordinated debt, equity and other capital | 4,203 | 7 | 299 | 433 | 398 | 364 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7,902 |
| 8 | Retail | 740 | 299 | 433 | 398 | 364 | 27 | 382 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3,451 |
| 9 | Real estate | 740 | 299 | 388 | 381 | 364 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2,778 |
| | Of which: general RRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 165 |
| | Of which: IPRRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 223 |
| | Of which: other RRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| | Of which: general CRE | 223 | 8 | 198 | 2 | 199 | 100 |
| | Of which: IPCRE | 202 | 3 | 201 | 1 | 215 | 106 |
| | Of which: land acquisition, development and construction | 44 | 78 | 44 | 31 | 113 | 151 |
| 10 | Reverse mortgages | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 11 | MBS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 12 | Defaulted exposures | 9,173 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8,696 |
| 13 | Other assets (1) | 17,869 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17,869 |
| 14 | Total | 15,226 | 4,203 | 2,793 | 299 | 433 | 398 | 364 | 27 | 736 | 24 | 254 | 3,724 | 5,337 | 33 | 12,813 | 5 | 172 | 374 | 258 | 47,473 |

Exposure amounts and CCFs applied to off-balance sheet exposures, categorized based on risk bucket of converted exposures.

($ millions)

| Risk weight | Q4/24 a | Q4/24 b | Q4/24 d | Q4/24 e | Q4/24 f |
|---|---|---|---|---|---|
| | On-balance sheet exposure | Off-balance sheet exposure (pre-CCF) | Weighted Average CCF% | Exposure (post-CCF and post-CRM) | RWA | Exposure density % |
| 1 | Less than 40% | 19,700 | 12,262 | 26% | 23,352 |
| 2 | 40-70% | 1,453 | 76 | 39% | 1,405 |
| 3 | 75-80% | 2,716 | 3,941 | 26% | 3,724 |
| 4 | 85% | 4,451 | 2,554 | 42% | 5,337 |
| 5 | 90-100% | 12,839 | 1,093 | 147% | 12,846 |
| 6 | 105-130% | 179 | 2 | 50% | 177 |
| 7 | 150% | 354 | 71 | 42% | 374 |
| 8 | 250% | 240 | 46 | 39% | 258 |
| 9 | 400% | - | - | - | - |
| 10 | 1250% | 41,932 | 20,045 | 34% | 47,473 |
| 11 | Total exposures | | | | | |

For footnotes, see page 34.

## CR5: SA - EXPOSURES BY ASSET CLASSES AND RISK-WEIGHTS (continued)

($ millions)

| Asset classes | Q3/24 Risk weight | | | | | | | | | | | | | | | | | | | | | | | | | | Total credit exposure amount (post-CCF and post-CRM) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | 0% | 15% | 20% | 25% | 30% | 35% | 40% | 45% | 50% | 55% | 60% | 65% | 70% | 75% | 80% | 85% | 90% | 100% | 105% | 110% | 130% | 150% | 250% | 400% | 1250% | Others |
| 1 | Sovereigns and their central banks | 6,147 | 12 | 61 | 256 | - | - | - | - | - | - | - | - | - | - | - | - | - | 621 | - | - | - | - | - | - | - | 6,480 |
| 2 | PSES | 62 | 159 | 269 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 621 | - | - | - | - | - | - | 1,196 |
| 3 | MDBs | 676 | - | - | 31 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 970 |
| 4 | Banks | 888 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 51 | - | - | - | - | - | - | 970 |
| | Of which: securities firms and other financial institutions treated as banks | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 5 | Covered bonds | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5,102 | - | - | - | - | 2,098 | - | - | - | - | 7,230 |
| 6 | Corporates | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 632 |
| | Of which: specialized lending | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 602 | - | - | - | - | 30 | - | - | - | - | - |
| 7 | Subordinated debt, equity and other capital | 4,084 | 7 | 226 | 424 | 398 | 368 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7,230 |
| 8 | Retail | 723 | 226 | 424 | 398 | 368 | 27 | 379 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7,544 |
| 9 | Real estate | 723 | 226 | 378 | 381 | 368 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3,325 |
| | Of which: general RRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2,682 |
| | Of which: IPRRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 166 |
| | Of which: other RRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| | Of which: general CRE | 223 | 8 | 198 | 2 | 199 | 100 |
| | Of which: IPCRE | 202 | 3 | 201 | 1 | 215 | 106 |
| | Of which: land acquisition, development and construction | 44 | 78 | 44 | 31 | 113 | 151 |
| 10 | Reverse mortgages | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 11 | MBS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 12 | Defaulted exposures | 9,193 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17,417 |
| 13 | Other assets (1) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 14 | Total | 15,402 | 4,084 | 2,465 | 226 | 424 | 398 | 368 | 27 | 740 | 20 | 257 | 3,486 | 5,102 | 22 | 12,264 | 5 | 173 | 376 | 232 | 46,071 |

Exposure amounts and CCFs applied to off-balance sheet exposures, categorized based on risk bucket of converted exposures.

($ millions)

| Risk weight | Q3/24 a | Q3/24 b | Q3/24 d | Q3/24 e | Q3/24 f |
|---|---|---|---|---|---|
| | On-balance sheet exposure | Off-balance sheet exposure (pre-CCF) | Weighted Average CCF% | Exposure (post-CCF and post-CRM) | RWA | Exposure density % |
| 1 | Less than 40% | 19,350 | 11,960 | 25% | 22,999 |
| 2 | 40-70% | 1,460 | 81 | 40% | 1,412 |
| 3 | 75-80% | 2,502 | 3,834 | 26% | 3,486 |
| 4 | 85% | 4,306 | 2,417 | 41% | 5,102 |
| 5 | 90-100% | 12,280 | 1,091 | 145% | 12,286 |
| 6 | 105-130% | 181 | 3 | 33% | 178 |
| 7 | 150% | 356 | 80 | 41% | 376 |
| 8 | 250% | 226 | 17 | 41% | 232 |
| 9 | 400% | - | - | - | - |
| 10 | 1250% | 40,661 | 19,483 | 34% | 46,071 |
| 11 | Total exposures | | | | | |

For footnotes, see page 34.

## CR5: SA - EXPOSURES BY ASSET CLASSES AND RISK-WEIGHTS (continued)

($ millions)

| Asset classes | Q2/24 Risk weight | | | | | | | | | | | | | | | | | | | | | | | | | | Total credit exposure amount (post-CCF and post-CRM) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | 0% | 15% | 20% | 25% | 30% | 35% | 40% | 45% | 50% | 55% | 60% | 65% | 70% | 75% | 80% | 85% | 90% | 100% | 105% | 110% | 130% | 150% | 250% | 400% | 1250% | Others |
| 1 | Sovereigns and their central banks | 6,458 | 20 | 76 | 241 | - | - | - | - | - | - | - | - | - | - | - | - | - | 581 | 99 | - | - | - | - | - | - | 6,799 |
| 2 | PSES | 65 | 165 | 246 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 581 | - | - | - | - | - | - | 1,156 |
| 3 | MDBs | 705 | - | - | 32 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 739 |
| 4 | Banks | 739 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 49 | - | - | - | - | - | - | 833 |
| | Of which: securities firms and other financial institutions treated as banks | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 5 | Covered bonds | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5,036 | - | - | - | - | 2,057 | - | - | - | - | 7,130 |
| 6 | Corporates | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 661 |
| | Of which: specialized lending | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 774 | - | - | - | - | 30 | - | - | - | - | - |
| 7 | Subordinated debt, equity and other capital | 4,676 | 7 | 264 | 436 | 365 | 357 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8,943 |
| 8 | Retail | 720 | 264 | 436 | 357 | 365 | 27 | 379 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3,300 |
| 9 | Real estate | 720 | 264 | 387 | 340 | 365 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2,681 |
| | Of which: general RRE | 49 | 17 | 27 | 24 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 168 |
| | Of which: IPRRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 197 |
| | Of which: other RRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| | Of which: general CRE | 219 | 5 | 196 | 1 | 197 | 100 |
| | Of which: IPCRE | 187 | 3 | 186 | 1 | 200 | 107 |
| | Of which: land acquisition, development and construction | 40 | 67 | 40 | 27 | 100 | 149 |
| 10 | Reverse mortgages | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 11 | MBS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 12 | Defaulted exposures | 17,592 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17,592 |
| 13 | Other assets (1) | 42,232 | 19,383 | 42,046 | 5,578 | 22,785 | 48 |
| 14 | Total | | | | | | | | | | | | | | | | | | | | | | | | | | |

($ millions)

| Risk weight | Q2/24 a | Q2/24 b | Q2/24 d | Q2/24 e | Q2/24 f |
|---|---|---|---|---|---|
| | On-balance sheet exposure | Off-balance sheet exposure (pre-CCF) | Weighted Average CCF% | Exposure (post-CCF and post-CRM) | RWA | Exposure density % |
| 1 | Less than 40% | 20,640 | 11,880 | 26% | 24,271 |
| 2 | 40-70% | 1,454 | 78 | 40% | 1,401 |
| 3 | 75-80% | 3,317 | 3,799 | 26% | 4,292 |
| 4 | 85% | 4,241 | 2,460 | 41% | 5,036 |
| 5 | 90-100% | 11,901 | 1,139 | 44% | 11,941 |
| 6 | 105-130% | 174 | 3 | 33% | 171 |
| 7 | 150% | 332 | 68 | 41% | 339 |
| 8 | 250% | 167 | 16 | 44% | 173 |
| 9 | 400% | - | - | - | - |
| 10 | 1250% | 42,226 | 19,443 | 29% | 47,624 |
| 11 | Total exposures | | | | | |

For footnotes, see page 34.

## CR5: SA - EXPOSURES BY ASSET CLASSES AND RISK-WEIGHTS (continued)

($ millions)

| Asset classes | Q1/24 Risk weight | | | | | | | | | | | | | | | | | | | | | | | | | | Total credit exposure amount (post-CCF and post-CRM) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | 0% | 15% | 20% | 25% | 30% | 35% | 40% | 45% | 50% | 55% | 60% | 65% | 70% | 75% | 80% | 85% | 90% | 100% | 105% | 110% | 130% | 150% | 250% | 400% | 1250% | Others |
| 1 | Sovereigns and their central banks | 5,939 | 11 | 76 | 266 | - | - | - | - | - | - | - | - | - | - | - | - | - | 603 | 90 | - | - | - | - | - | - | 6,411 |
| 2 | PSES | 81 | 174 | 238 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 570 | - | - | - | - | - | - | 641 |
| 3 | MDBs | 570 | - | - | 13 | - | - | - | - | - | - | - | - | - | - | - | - | - | 8 | - | - | - | - | - | - | 589 |
| 4 | Banks | 641 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 14 | - | - | - | - | - | - | 641 |
| | Of which: securities firms and other financial institutions treated as banks | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 5 | Covered bonds | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4,771 | - | - | - | - | 1,922 | - | - | - | - | 6,728 |
| 6 | Corporates | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 555 |
| | Of which: specialized lending | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 527 | - | - | - | - | 28 | - | - | - | - | - |
| 7 | Subordinated debt, equity and other capital | 5,237 | 7 | 258 | 421 | 356 | 285 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 909 |
| 8 | Retail | 717 | 258 | 421 | 356 | 285 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8,736 |
| 9 | Real estate | 717 | 258 | 372 | 339 | 285 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3,172 |
| | Of which: general RRE | 49 | 17 | 27 | 25 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2,570 |
| | Of which: IPRRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 161 |
| | Of which: other RRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| | Of which: general CRE | 224 | 2 | 201 | 1 | 201 | 100 |
| | Of which: IPCRE | 172 | 3 | 171 | 1 | 184 | 107 |
| | Of which: land acquisition, development and construction | 55 | 30 | 55 | 12 | 101 | 151 |
| 10 | Reverse mortgages | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 11 | MBS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 12 | Defaulted exposures | 382 | 1 | 177 | 1 | 209 | 117 |
| 13 | Other assets (1) | 16,171 | - | 16,171 | - | 7,736 | 48 |
| 14 | Total | 14,270 | 5,237 | 2,300 | 258 | 434 | 356 | 285 | 25 | 697 | 19 | 253 | 3,521 | 4,771 | 13 | 11,543 | 5 | 152 | 272 | 176 | 44,587 |

Exposure amounts and CCFs applied to off-balance sheet exposures, categorized based on risk bucket of converted exposures.

($ millions)

| Risk weight | Q1/24 a | Q1/24 b | Q1/24 d | Q1/24 e | Q1/24 f |
|---|---|---|---|---|---|
| | On-balance sheet exposure | Off-balance sheet exposure (pre-CCF) | Weighted Average CCF% | Exposure (post-CCF and post-CRM) | RWA | Exposure density % |
| 1 | Less than 40% | 18,797 | 13,386 | 26% | 22,855 |
| 2 | 40-70% | 1,348 | 61 | 41% | 1,279 |
| 3 | 75-80% | 2,896 | 2,429 | 26% | 3,521 |
| 4 | 85% | 4,120 | 2,171 | 41% | 4,771 |
| 5 | 90-100% | 11,567 | 1,099 | 43% | 11,556 |
| 6 | 105-130% | 160 | 3 | 33% | 157 |
| 7 | 150% | 268 | 31 | 42% | 272 |
| 8 | 250% | 161 | 37 | 41% | 176 |
| 9 | 400% | - | - | - | - |
| 10 | 1250% | 39,317 | 19,217 | 28% | 44,587 |
| 11 | Total exposures | | | | | |

For footnotes, see page 34.

## CR6: IRB - CREDIT RISK EXPOSURES BY PORTFOLIO AND PD RANGE (1)

($ millions)

| AIRB approach PD scale | Q1/25 a | Q1/25 b | Q1/25 c | Q1/25 d | Q1/25 e | Q1/25 f | Q1/25 g | Q1/25 h | Q1/25 i | Q1/25 k |
|---|---|---|---|---|---|---|---|---|---|---|
| | Original on-balance sheet gross exposure | Off-balance sheet exposures pre CCF | Average CCF % | EAD post-CRM and post-CCF | Average PD % | Number of obligors (2) | Average LGD % | Average maturity (3) | RWA (4) | RWA density % | Expected losses (5) | Provisions (5) |
| **Business and government portfolios** | | | | | | | | | | | | |
| **Corporate** | | | | | | | | | | | | |
| 0.00 to <0.15 | 15,833 | 9,064 | 59 | 21,226 | 0.06 | 2,583 | 26 | 2.3 | 2,799 | 13 | 4 |
| 0.15 to <0.25 | 19,196 | 10,280 | 54 | 24,712 | 0.19 | 4,733 | 39 | 2.0 | 8,149 | 33 | 19 |
| 0.25 to <0.50 | 16,028 | 8,690 | 52 | 20,573 | 0.34 | 3,351 | 39 | 1.9 | 8,855 | 43 | 27 |
| 0.50 to <0.75 | 17,458 | 8,283 | 47 | 21,338 | 0.58 | 3,259 | 39 | 1.8 | 11,822 | 55 | 48 |
| 0.75 to <2.50 | 34,233 | 15,749 | 46 | 41,529 | 1.12 | 6,413 | 41 | 2.1 | 32,858 | 79 | 192 |
| 2.50 to <10.00 | 11,211 | 4,887 | 47 | 13,519 | 3.38 | 27,112 | 40 | 1.9 | 14,360 | 106 | 185 |
| 10.00 to 100.00 | 5,399 | 1,051 | 49 | 5,913 | 20.87 | 718 | 44 | 1.6 | 12,205 | 206 | 560 |
| 100.00 (Default) | 1,522 | 165 | 42 | 1,591 | 100.00 | 585 | 34 | 1.9 | 3,285 | 206 | 295 |
| **Total** | 120,880 | 58,169 | 51 | 150,401 | 2.66 | 48,754 | 38 | 2.0 | 94,333 | 63 | 1,330 | 1,433 |
| **Corporate specialized lending** | | | | | | | | | | | | |
| 0.00 to <0.15 | 453 | 902 | 75 | 1,127 | 0.06 | 15 | 31 | 1.5 | 137 | 12 |
| 0.15 to <0.25 | 3,211 | 3,014 | 54 | 4,849 | 0.19 | 100 | 29 | 2.8 | 1,406 | 29 | 3 |
| 0.25 to <0.50 | 2,793 | 1,959 | 54 | 3,857 | 0.34 | 74 | 26 | 2.7 | 1,367 | 35 | 3 |
| 0.50 to <0.75 | 4,498 | 3,916 | 49 | 6,427 | 0.58 | 137 | 27 | 2.9 | 3,156 | 49 | 10 |
| 0.75 to <2.50 | 6,897 | 4,669 | 46 | 9,044 | 1.01 | 223 | 31 | 2.8 | 6,074 | 67 | 30 |
| 2.50 to <10.00 | 908 | 716 | 46 | 1,239 | 2.87 | 46 | 35 | 2.2 | 1,221 | 99 | 13 |
| 10.00 to 100.00 | 87 | 45 | 63 | 115 | 22.44 | 9 | 41 | 1.6 | 234 | 203 |
| 100.00 (Default) | 50 | 100.00 | 1 | 25 | 2.5 | - | - |
| **Sovereign** | 18,847 | 15,221 | 51 | 26,658 | 0.80 | 605 | 29 | 2.7 | 13,595 | 51 | 69 | 28 |
| 0.00 to <0.15 | 191,638 | 17,093 | 56 | 201,193 | 0.02 | 1,461 | 8 | 2.3 | 4,007 | 2 | 4 |
| 0.15 to <0.25 | 441 | 559 | 46 | 696 | 0.22 | 73 | 26 | 2.5 | 177 | 25 |
| 0.25 to <0.50 | 50 | 31 | 64 | 70 | 0.34 | 48 | 53 | 1.8 | 44 | 63 |
| 0.50 to <0.75 | 153 | 55 | 43 | 177 | 0.58 | 25 | 26 | 2.4 | 71 | 40 |
| 0.75 to <2.50 | 57 | 20 | 59 | 69 | 1.17 | 43 | 29 | 1.3 | 36 | 52 |
| 2.50 to <10.00 | 19 | 26 | 44 | 31 | 3.13 | 349 | 30 | 2.0 | 26 | 84 |
| 10.00 to 100.00 | 5 | 2 | 63 | 6 | 16.23 | 6 | 49 | 1.4 | 14 | 233 |
| 100.00 (Default) | - | - | - | - | - | - | - | - | - | - |
| **Banks (6)** | 192,363 | 17,786 | 56 | 202,242 | 0.02 | 2,005 | 8 | 2.3 | 4,375 | 2 | 4 | 1 |
| 0.00 to <0.15 | 4,902 | 36 | 51 | 4,921 | 0.01 | 29 | 5 | 2.8 | 46 | 1 |
| **Total** | 19,078 | 4,132 | 2,825 | 326 | 441 | 398 | 369 | 27 | 771 | 26 | 255 | 4,056 | 5,389 | 46 | 12,843 | 5 | 155 | 264 | 277 | 20,437 |

Exposure amounts and CCFs applied to off-balance sheet exposures, categorized based on risk bucket of converted exposures.

($ millions)

| Risk weight | Q1/25 a | Q1/25 b | Q1/25 d | Q1/25 e | Q1/25 f |
|---|---|---|---|---|---|
| | On-balance sheet exposure | Off-balance sheet exposure (pre-CCF) | Weighted Average CCF% | Exposure (post-CCF and post-CRM) | RWA | Exposure density % |
| 1 | Less than 40% | 23,494 | 12,481 | 26% | 27,200 |
| 2 | 40-70% | 1,492 | 80 | 40% | 1,448 |
| 3 | 75-80% | 2,938 | 4,371 | 26% | 4,056 |
| 4 | 85% | 4,435 | 2,252 | 44% | 5,389 |
| 5 | 90-100% | 12,870 | 1,323 | 46% | 12,889 |
| 6 | 105-130% | 163 | 0 | 0% | 160 |
| 7 | 150% | 258 | 59 | 42% | 264 |
| 8 | 250% | 258 | 47 | 40% | 277 |
| 9 | 400% | - | - | - | - |
| 10 | 1250% | 45,900 | 20,613 | 29% | 51,683 |
| 11 | Total exposures | | | | | |

(1) Excludes exposures that are deducted from regulatory capital.
(2) Weighting is based on off-balance sheet exposure (pre-CCF).

## CR5: SA - EXPOSURES BY ASSET CLASSES AND RISK-WEIGHTS (continued)

($ millions)

| Asset classes | Q4/24 Risk weight | | | | | | | | | | | | | | | | | | | | | | | | | | Total credit exposure amount (post-CCF and post-CRM) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | 0% | 15% | 20% | 25% | 30% | 35% | 40% | 45% | 50% | 55% | 60% | 65% | 70% | 75% | 80% | 85% | 90% | 100% | 105% | 110% | 130% | 150% | 250% | 400% | 1250% | Others |
| 1 | Sovereigns and their central banks | 5,993 | 12 | 72 | 251 | - | - | - | - | - | - | - | - | - | - | - | - | - | 611 | 68 | - | - | - | - | - | - | 6,328 |
| 2 | PSES | 60 | 113 | 261 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 611 | - | - | - | - | - | - | 1,113 |
| 3 | MDBs | 696 | - | - | 21 | - | - | - | - | - | - | - | - | - | - | - | - | - | 12 | - | - | - | - | - | - | 696 |
| 4 | Banks | 1,225 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 40 | - | - | - | - | - | - | 1,298 |
| | Of which: securities firms and other financial institutions treated as banks | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 5 | Covered bonds | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5,337 | - | - | - | - | 2,123 | - | - | - | - | 7,485 |
| 6 | Corporates | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 613 |
| | Of which: specialized lending | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 780 | - | - | - | - | 258 | - | - | - | - | - |
| 7 | Subordinated debt, equity and other capital | 4,203 | 7 | 299 | 433 | 398 | 364 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7,902 |
| 8 | Retail | 740 | 299 | 433 | 398 | 364 | 27 | 382 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3,451 |
| 9 | Real estate | 740 | 299 | 388 | 381 | 364 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2,778 |
| | Of which: general RRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 165 |
| | Of which: IPRRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 223 |
| | Of which: other RRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| | Of which: general CRE | 223 | 8 | 198 | 2 | 199 | 100 |
| | Of which: IPCRE | 202 | 3 | 201 | 1 | 215 | 106 |
| | Of which: land acquisition, development and construction | 44 | 78 | 44 | 31 | 113 | 151 |
| 10 | Reverse mortgages | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 11 | MBS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 12 | Defaulted exposures | 9,173 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17,869 |
| 13 | Other assets (1) | 17,869 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17,869 |
| 14 | Total | 15,226 | 4,203 | 2,793 | 299 | 433 | 398 | 364 | 27 | 736 | 24 | 254 | 3,724 | 5,337 | 33 | 12,813 | 5 | 172 | 374 | 258 | 47,473 |

Exposure amounts and CCFs applied to off-balance sheet exposures, categorized based on risk bucket of converted exposures.

($ millions)

| Risk weight | Q4/24 a | Q4/24 b | Q4/24 d | Q4/24 e | Q4/24 f |
|---|---|---|---|---|---|
| | On-balance sheet exposure | Off-balance sheet exposure (pre-CCF) | Weighted Average CCF% | Exposure (post-CCF and post-CRM) | RWA | Exposure density % |
| 1 | Less than 40% | 19,700 | 12,262 | 26% | 23,352 |
| 2 | 40-70% | 1,453 | 76 | 39% | 1,405 |
| 3 | 75-80% | 2,716 | 3,941 | 26% | 3,724 |
| 4 | 85% | 4,451 | 2,554 | 42% | 5,337 |
| 5 | 90-100% | 12,839 | 1,093 | 147% | 12,846 |
| 6 | 105-130% | 179 | 2 | 50% | 177 |
| 7 | 150% | 354 | 71 | 42% | 374 |
| 8 | 250% | 240 | 46 | 39% | 258 |
| 9 | 400% | - | - | - | - |
| 10 | 1250% | 41,932 | 20,045 | 34% | 47,473 |
| 11 | Total exposures | | | | | |

For footnotes, see page 34.

## CR5: SA - EXPOSURES BY ASSET CLASSES AND RISK-WEIGHTS (continued)

($ millions)

| Asset classes | Q3/24 Risk weight | | | | | | | | | | | | | | | | | | | | | | | | | | Total credit exposure amount (post-CCF and post-CRM) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | 0% | 15% | 20% | 25% | 30% | 35% | 40% | 45% | 50% | 55% | 60% | 65% | 70% | 75% | 80% | 85% | 90% | 100% | 105% | 110% | 130% | 150% | 250% | 400% | 1250% | Others |
| 1 | Sovereigns and their central banks | 6,147 | 12 | 61 | 256 | - | - | - | - | - | - | - | - | - | - | - | - | - | 621 | - | - | - | - | - | - | - | 6,480 |
| 2 | PSES | 62 | 159 | 269 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 621 | - | - | - | - | - | - | 1,196 |
| 3 | MDBs | 676 | - | - | 31 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 970 |
| 4 | Banks | 888 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 31 | - | - | - | - | - | - | 970 |
| | Of which: securities firms and other financial institutions treated as banks | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 5 | Covered bonds | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5,102 | - | - | - | - | 2,098 | - | - | - | - | 7,230 |
| 6 | Corporates | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 632 |
| | Of which: specialized lending | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 602 | - | - | - | - | 30 | - | - | - | - | - |
| 7 | Subordinated debt, equity and other capital | 4,084 | 7 | 226 | 424 | 398 | 368 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7,544 |
| 8 | Retail | 723 | 226 | 424 | 398 | 368 | 27 | 379 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3,325 |
| 9 | Real estate | 723 | 226 | 378 | 381 | 368 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2,682 |
| | Of which: general RRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 166 |
| | Of which: IPRRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 200 |
| | Of which: other RRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| | Of which: general CRE | 223 | 8 | 198 | 2 | 199 | 100 |
| | Of which: IPCRE | 202 | 3 | 201 | 1 | 215 | 106 |
| | Of which: land acquisition, development and construction | 44 | 78 | 44 | 31 | 113 | 151 |
| 10 | Reverse mortgages | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 11 | MBS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 12 | Defaulted exposures | 9,193 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 12,382 |
| 13 | Other assets (1) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 14 | Total | 15,402 | 4,084 | 2,465 | 226 | 424 | 398 | 368 | 27 | 740 | 20 | 257 | 3,486 | 5,102 | 22 | 12,264 | 5 | 173 | 376 | 232 | 46,071 |

Exposure amounts and CCFs applied to off-balance sheet exposures, categorized based on risk bucket of converted exposures.

($ millions)

| Risk weight | Q3/24 a | Q3/24 b | Q3/24 d | Q3/24 e | Q3/24 f |
|---|---|---|---|---|---|
| | On-balance sheet exposure | Off-balance sheet exposure (pre-CCF) | Weighted Average CCF% | Exposure (post-CCF and post-CRM) | RWA | Exposure density % |
| 1 | Less than 40% | 19,350 | 11,960 | 25% | 22,999 |
| 2 | 40-70% | 1,460 | 81 | 40% | 1,412 |
| 3 | 75-80% | 2,502 | 3,834 | 26% | 3,486 |
| 4 | 85% | 4,306 | 2,417 | 41% | 5,102 |
| 5 | 90-100% | 12,280 | 1,091 | 145% | 12,286 |
| 6 | 105-130% | 181 | 3 | 33% | 178 |
| 7 | 150% | 356 | 80 | 41% | 376 |
| 8 | 250% | 226 | 17 | 41% | 232 |
| 9 | 400% | - | - | - | - |
| 10 | 1250% | 40,661 | 19,483 | 34% | 46,071 |
| 11 | Total exposures | | | | | |

For footnotes, see page 34.

## CR5: SA - EXPOSURES BY ASSET CLASSES AND RISK-WEIGHTS (continued)

($ millions)

| Asset classes | Q2/24 Risk weight | | | | | | | | | | | | | | | | | | | | | | | | | | Total credit exposure amount (post-CCF and post-CRM) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | 0% | 15% | 20% | 25% | 30% | 35% | 40% | 45% | 50% | 55% | 60% | 65% | 70% | 75% | 80% | 85% | 90% | 100% | 105% | 110% | 130% | 150% | 250% | 400% | 1250% | Others |
| 1 | Sovereigns and their central banks | 6,458 | 20 | 76 | 241 | - | - | - | - | - | - | - | - | - | - | - | - | - | 581 | 99 | - | - | - | - | - | - | 6,799 |
| 2 | PSES | 65 | 165 | 246 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 581 | - | - | - | - | - | - | 1,156 |
| 3 | MDBs | 705 | - | - | 32 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 739 |
| 4 | Banks | 739 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 49 | - | - | - | - | - | - | 833 |
| | Of which: securities firms and other financial institutions treated as banks | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 5 | Covered bonds | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5,036 | - | - | - | - | 2,057 | - | - | - | - | 7,130 |
| 6 | Corporates | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 661 |
| | Of which: specialized lending | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 774 | - | - | - | - | 30 | - | - | - | - | - |
| 7 | Subordinated debt, equity and other capital | 4,676 | 7 | 264 | 436 | 365 | 355 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8,943 |
| 8 | Retail | 720 | 264 | 436 | 357 | 365 | 27 | 379 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3,300 |
| 9 | Real estate | 720 | 264 | 387 | 340 | 365 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2,681 |
| | Of which: general RRE | 49 | 17 | 27 | 24 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 168 |
| | Of which: IPRRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 197 |
| | Of which: other RRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| | Of which: general CRE | 219 | 5 | 196 | 1 | 197 | 100 |
| | Of which: IPCRE | 187 | 3 | 186 | 1 | 200 | 107 |
| | Of which: land acquisition, development and construction | 40 | 67 | 40 | 27 | 100 | 149 |
| 10 | Reverse mortgages | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 11 | MBS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 12 | Defaulted exposures | 17,592 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17,592 |
| 13 | Other assets (1) | 42,232 | 19,383 | 42,046 | 5,578 | 22,785 | 48 |
| 14 | Total | | | | | | | | | | | | | | | | | | | | | | | | | | |

($ millions)

| Risk weight | Q2/24 a | Q2/24 b | Q2/24 d | Q2/24 e | Q2/24 f |
|---|---|---|---|---|---|
| | On-balance sheet exposure | Off-balance sheet exposure (pre-CCF) | Weighted Average CCF% | Exposure (post-CCF and post-CRM) | RWA | Exposure density % |
| 1 | Less than 40% | 20,640 | 11,880 | 26% | 24,271 |
| 2 | 40-70% | 1,454 | 78 | 40% | 1,401 |
| 3 | 75-80% | 3,317 | 3,799 | 26% | 4,292 |
| 4 | 85% | 4,241 | 2,460 | 41% | 5,036 |
| 5 | 90-100% | 11,901 | 1,139 | 44% | 11,941 |
| 6 | 105-130% | 174 | 3 | 33% | 171 |
| 7 | 150% | 332 | 68 | 41% | 339 |
| 8 | 250% | 167 | 16 | 44% | 173 |
| 9 | 400% | - | - | - | - |
| 10 | 1250% | 42,226 | 19,443 | 29% | 47,624 |
| 11 | Total exposures | | | | | |

For footnotes, see page 34.

## CR5: SA - EXPOSURES BY ASSET CLASSES AND RISK-WEIGHTS (continued)

($ millions)

| Asset classes | Q1/24 Risk weight | | | | | | | | | | | | | | | | | | | | | | | | | | Total credit exposure amount (post-CCF and post-CRM) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | 0% | 15% | 20% | 25% | 30% | 35% | 40% | 45% | 50% | 55% | 60% | 65% | 70% | 75% | 80% | 85% | 90% | 100% | 105% | 110% | 130% | 150% | 250% | 400% | 1250% | Others |
| 1 | Sovereigns and their central banks | 5,939 | 11 | 76 | 266 | - | - | - | - | - | - | - | - | - | - | - | - | - | 603 | 90 | - | - | - | - | - | - | 6,296 |
| 2 | PSES | 81 | 174 | 238 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 570 | - | - | - | - | - | - | 641 |
| 3 | MDBs | 570 | - | - | 13 | - | - | - | - | - | - | - | - | - | - | - | - | - | 8 | - | - | - | - | - | - | 589 |
| 4 | Banks | 641 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 14 | - | - | - | - | - | - | 641 |
| | Of which: securities firms and other financial institutions treated as banks | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 5 | Covered bonds | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4,771 | - | - | - | - | 1,922 | - | - | - | - | 6,728 |
| 6 | Corporates | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 555 |
| | Of which: specialized lending | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 527 | - | - | - | - | 28 | - | - | - | - | - |
| 7 | Subordinated debt, equity and other capital | 4,774 | 7 | 250 | 421 | 356 | 285 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7,689 |
| 8 | Retail | 717 | 258 | 421 | 356 | 285 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3,172 |
| 9 | Real estate | 717 | 258 | 372 | 339 | 285 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2,570 |
| | Of which: general RRE | 49 | 17 | 25 | 22 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 161 |
| | Of which: IPRRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 202 |
| | Of which: other RRE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| | Of which: general CRE | 224 | 2 | 201 | 1 | 201 | 100 |
| | Of which: IPCRE | 172 | 3 | 171 | 1 | 184 | 107 |
| | Of which: land acquisition, development and construction | 55 | 30 | 55 | 12 | 101 | 151 |
| 10 | Reverse mortgages | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 11 | MBS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 12 | Defaulted exposures | 382 | 1 | 177 | 1 | 209 | 117 |
| 13 | Other assets (1) | 16,171 | - | 16,171 | - | 7,736 | 48 |
| 14 | Total | 14,270 | 5,237 | 2,300 | 258 | 434 | 356 | 285 | 25 | 697 | 19 | 253 | 3,521 | 4,771 | 13 | 11,543 | 5 | 152 | 272 | 176 | 44,587 |

Exposure amounts and CCFs applied to off-balance sheet exposures, categorized based on risk bucket of converted exposures.

($ millions)

| Risk weight | Q1/24 a | Q1/24 b | Q1/24 d | Q1/24 e | Q1/24 f |
|---|---|---|---|---|---|
| | On-balance sheet exposure | Off-balance sheet exposure (pre-CCF) | Weighted Average CCF% | Exposure (post-CCF and post-CRM) | RWA | Exposure density % |
| 1 | Less than 40% | 18,797 | 13,386 | 26% | 22,855 |
| 2 | 40-70% | 1,348 | 61 | 41% | 1,279 |
| 3 | 75-80% | 2,896 | 2,429 | 26% | 3,521 |
| 4 | 85% | 4,120 | 2,171 | 41% | 4,771 |
| 5 | 90-100% | 11,567 | 1,099 | 43% | 11,556 |
| 6 | 105-130% | 160 | 3 | 33% | 157 |
| 7 | 150% | 268 | 31 | 42% | 272 |
| 8 | 250% | 161 | 37 | 41% | 176 |
| 9 | 400% | - | - | - | - |
| 10 | 1250% | 39,317 | 19,217 | 28% | 44,587 |
| 11 | Total exposures | | | | | |

For footnotes, see page 34.

## CR6: IRB - CREDIT RISK EXPOSURES BY PORTFOLIO AND PD RANGE (1)

($ millions)

| AIRB approach PD scale | Q1/25 a | Q1/25 b | Q1/25 c | Q1/25 d | Q1/25 e | Q1/25 f | Q1/25 g | Q1/25 h | Q1/25 i | Q1/25 k |
|---|---|---|---|---|---|---|---|---|---|---|
| | Original on-balance sheet gross exposure | Off-balance sheet exposures pre CCF | Average CCF % | EAD post-CRM and post-CCF | Average PD % | Number of obligors (2) | Average LGD % | Average maturity (3) | RWA (4) | RWA density % | Expected losses (5) | Provisions (5) |
| **Business and government portfolios** | | | | | | | | | | | | |
| **Corporate** | | | | | | | | | | | | |
| 0.00 to <0.15 | 16,090 | 27,776 | 38 | 26,648 | 0.08 | 531 | 32 | 1.7 | 4,721 | 18 | 7 |
| 0.15 to <0.25 | 12,240 | 21,816 | 39 | 20,773 | 0.18 | 575 | 36 | 2.1 | 7,064 |